Cyclolignan Synthesis Streamlined by Enantioselective Hydrogenation of Tetrasubstituted Olefins

Cyclolignan Synthesis Streamlined by Enantioselective Hydrogenation of Tetrasubstituted Olefins | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Physical Sciences - Article Cyclolignan Synthesis Streamlined by Enantioselective Hydrogenation of Tetrasubstituted Olefins Wen-Xiu Xu, Zhuo Peng, Qing-Xiu Gu, Yao Zhu, Li-Han Zhao, Hai-Hua Lu This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-2924400/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 20 Jun, 2024 Read the published version in Nature Synthesis → Version 1 posted You are reading this latest preprint version Abstract All Birds with One Stone: Natural products have long been valuable sources of inspiration for drug discovery. Unfortunately, the inherent limitations of direct semisynthetic derivatizations have become more and more obvious, and the need to overcome these limitations is particularly urgent nowadays because the most valuable natural products tend to be isolated in minute amounts. Therefore, de novo synthesis with ideal modularity and diversity, have been a critical goal in drug discovery research. However, this endeavor of complex natural products is highly challenging, and only limited success has been achieved so far. Herein, we report a powerful, general platform for cyclolignan synthesis involving challenging rhodium-catalyzed enantioselective hydrogenation of tetrasubstituted 1,2-dihydronaphthalene esters (> 40 examples; up to 99% y, >99% ee). This unique platform allows ready access to various types of cyclolignans, as exemplified by the expedient and mostly protecting-group-free synthesis of over thirty cyclolignans, including many that have not previously been synthesized, such as 6-methoxy podophyllotoxin, cleistantoxin, picrobursenin, austrobailignan-4, aglacins D and F-H (with three revised structures), (+)-lirionol, ovafolinin D, and fimbricalyxoid A. We expect this work to inspire modular, de novo diversity-oriented syntheses of other important classes of natural products and thus to rejuvenate the role of natural products in drug discovery and development. Physical sciences/Chemistry/Chemical synthesis/Asymmetric synthesis Physical sciences/Chemistry/Chemical synthesis/Diversity-oriented synthesis Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Figure 7 Main Text Cyclolignans also known as aryltetralins, are a family of miscellaneous lignan natural products that are found in many plant species and that display intriguing structural diversity and biological activities (such as anticancer, anti-tubulin polymerization, antiviral, antibacterial, antineoplastic, cytotoxic, and antimalarial activities). 19, 20 For example, podophyllotoxin (PPT), 21 one of the most well-known cyclolignans, shows exceptional cytotoxicity to a variety of cancer cell lines through binding to the colchicine site of the tubulin subunit and thus inhibiting microtubule assembly. Accordingly, PPT has for decades been the focus of chemical synthesis and the development of related anticancer drugs. 22,23 Considerable structural modification of PPT has led to numerous derivatives with activities against various types of cancers, and several derivatives are currently in clinical use, including the DNA-topoisomerase II inhibitors teniposide and etoposide (which is on the WTO’s list of essential medicines). Unfortunately, the therapeutic potential of PPT derivatives is often hampered by their poor bioavailability and the development of drug resistance. In addition, subtle changes in the aromatic rings of the parent PPT scaffold have been reported to dramatically influence their inhibitory activities. Tackling these issues will require that inherently exhaustible classical semisynthetic derivatization approaches to cyclolignans, which rely heavily on natural sources and are handicapped by the inflexible structural features of such sources, be supplemented with more powerful, diversity-oriented de novo strategies. 24,25 In 2014, Thomson and coworkers reported diversity-oriented synthesis (DOS) of six cyclolignans by means of novel tandem stereoselective oxidative [3,3]-sigmatropic rearrangement/Friedel-Crafts arylation reactions between electron-rich arenes and N -allylhydrazones (Fig. 1a), 26 and Maimone and Ting reported DOS of PPT and some 7’-aryl analogs via elegant Pd-catalyzed C(sp 3 )–H arylation reactions (Fig. 1b). 27 These pioneering studies provoked further exploration of divergent syntheses of cyclolignans. 28-33 Recently, the groups of Renata, 30 and Kroutil, Fuchs and colleagues 31 independently reported the intriguing chemoenzymatic total syntheses of (−)-PPT and a few related lactone cyclolignans by means of a nonheme dioxygenase 2-ODD-PH-catalyzed intramolecular oxidative cyclizations (Fig. 1c). Meanwhile, Zhu and coworkers developed a method for unusual radical-cation cascade reactions of dicinnamyl ethers that involved visible-light photoredox catalysis to facilitate concise, diastereoselective syntheses of several cyclic ether cyclolignans (Fig. 1d). 32 More recently, Gao and coworkers achieved asymmetric total syntheses of cyclic ether cyclolignans aglacins A, B, and E via interesting chiral Ti-mediated photoenolization/Diels–Alder reactions between electron-rich 2-methylbenzaldehydes and unsaturated γ-lactones (Fig. 1e). 33 Motivated by these impressive advances and coupled with our continuing interest in natural products as leads for drug development by de novo DOS, 34 we embarked on a search for a far more general platform for cyclolignan synthesis with the hope of achieving ideal modularity and diversity. Cognizant of the fact that cyclolignans share a common feature: the aryl substituent at C-7′ is either syn - or anti - to the substituent at C-8′, 19-25 we conjectured that the asymmetric hydrogenation of 1,2-dihydronaphthalene tetrasubstituted olefins 1 as information-rich hidden retrons, 35 comprising the vital scaffold and functionalities of cyclolignans and have a deliberately installed ester group to serve as a handle for subsequent epimerization and other manipulations, might provide a universal platform for cyclolignan synthesis (Fig. 1f). In addition, we expected that olefins 1 would be easily accessible from readily available 1-tetralones. However, we also envisioned the pivotal asymmetric hydrogenation of the tetrasubstituted olefins 1 to present a paramount challenge; as work on hydrogenation of tetrasubstituted olefins has progressed relatively slowly and appears to be rather limited, 36-39 in marked contrast to di- and trisubstituted olefins. Furthermore, to the best of our knowledge, there have been only a few studies, with limited success, on hydrogenation of simple unfunctionalized or non-activated tetrasubstituted α,β-unsaturated carboxylic acid esters; and the reported instances all require chiral Ru or Ir catalysis. 40-42 Asymmetric hydrogenation of unfunctionalized 1,2-dihydronaphthalene tetrasubstituted olefins (e.g., 3a and 3b ) was pioneered by Buchwald and coworkers, 43 who used a highly active chiral Zr catalyst, and was later investigated by the groups of Pfaltz 44 and others, 45-46 who frequently used more practical chiral Ir or Ru catalysts; almost concurrently, Zhang and coworkers 47 reported the first and only example of amino-functionalized olefin 5 utilizing a chiral Rh-PennPhos Catalyst (Fig. 1g). However, good reactivities and enantiomeric outcomes were observed for only a handful of 1,2-dihydronaphthalene tetrasubstituted olefins with these catalysts. Indeed, we found asymmetric hydrogenation of the desired dihydronaphthalene-based tetrasubstituted olefins bearing an ester group ( 1 ) to be very challenging (see Supplementary Information for detailed optimization data). After considerable investigation, we finally succeeded with the aid of a powerful new chiral Rh catalyst generated in situ from a combination of Rh(COD) 2 BAr F 4 and relatively less hindered ( R , R ) or ( S , S )-BDPP as a ligand (Fig. 2). Notably, to our knowledge, this represents the first successful application of Skewphos for enantioselective hydrogenation of tetrasubstituted olefins. 48,49 This new chiral Rh catalyst generally afforded excellent results (Fig. 2). We began by evaluating olefins with various substituents at C-7′ ( 2a – v ). The reactions of all the substrates with aromatic substituents ( 2a – s ) proceeded smoothly and gave excellent results, regardless of the steric or electronic properties of their ortho , meta , and para substituents (90–99% y and 90–99% ee). Pleasingly, olefins with a vinyl ( 1t ) or an alkyl substituent ( 1u and 1v ) were also suitable, giving hydrogenation products 2t – v with excellent outcomes (95–99% y and 90–95% ee). Next, we examined substrates with various substituents on the dihydronaphthalene ring ( 2w – o′ ). To our delight, substrates with a single electron-withdrawing or electron-donating para substituent gave excellent results ( 2w – c′ , 90–97% y and 96–99% ee). Moreover, substrates with a meta ( 1d′ and 1e′ ) or ortho ( 1f′ ) substituent or multiple substituents ( 1g′ – o′ ) were also amenable to this transformation, giving corresponding hydrogenation products 2d′ – o′ in 94–99% y with 93–99% ee. Notably, good tolerance of various functional groups was generally observed as well. Having developed a protocol for asymmetric hydrogenation reactions to establish the two crucial vicinal stereocenters, we commenced work on the pivotal DOS of cyclolignans, beginning with the divergent synthesis of the well-known cyclolignan PPT and related natural products (Fig. 3). We found that three methods were feasible with comparable results for selective benzylic C–H oxidation 50 of hydrogenation product 2p : CrO 3 -DMP-, copper-, and photoredox-mediated oxidations, gave desired ketone 7 . An aldol reaction of 7 with formaldehyde and subsequent lactonization afforded podophyllone ( 8 ), along with some double aldol product 9 . Mild Pd-catalyzed reduction of 8 with polymethylhydrosiloxane as the reductant 51 was found to be a good alternative to previously reported reducing agents (such as LiBH 4 and L-Selectride) for accessing either (−)-PPT ( 10 ) or deoxypodophyllotoxin ( 11 ). Epimerization of deoxypodophyllotoxin ( 11 ) afforded deoxypicropodophyllotoxin ( 12 ), while sequential reductions of 11 completed the first total synthesis of austrobailignan-4 ( 14 ). In addition, a thermal retro-aldol reaction of 9 afforded isopicropodophyllone ( 15 ), which could be reduced to generate either epiisopicropodophyllotoxin ( 16 ) 52 or epiisopicrodeoxypodophyllotoxin ( 17 ). Using this new protocol from either 2k′ or 2l′ , we also synthesized β-peltatin-A-methyether ( 18 ) and accomplished the first total syntheses of epiisopicropodophyllotoxin ( 16 ), 6-methoxypodophyllotoxin ( 19 ), 6-methoxypodophyllotoxin-7- O - n -hexanoate ( 20 ), 53 cleistantoxin ( 21 ), 54 and picrobursenin ( 22 ) 55 (Fig. 3b). Because of the electron-withdrawing ester group, 2p could be easily epimerized to provide 23 , from which other types of cyclolignans could be readily accessed (Fig. 4). For example, podophyllic aldehyde A ( 25 ) was obtained from 23 via four simple transformations. Global reduction of 25 , followed by selective oxidation of the resulting allylic alcohol, provided podophyllic aldehyde C ( 26 ), from which α-conidendrin analogue 27 , oleralignan A analogue 28 , and the nominal formosolactone ( 29 ) 56 were prepared via several simple transformations. Meanwhile, converting the ester group of 23 to a methyl group paved the way for the synthesis of analogues ( 33-36 ) of 8’- epi -aristoligone, cyclogalgravin analogue, galbulin/galcatin, and 8,8’- epi -aristoligone. We expect that the authentic natural products would be accessible from hydrogenation products 2l or 2n ′ – p ′ by means of the same established sequences. More types of interesting cyclolignans could be readily synthesized as exemplified from hydrogenation product 2j′ in Figs. 5 and 6. For instance, a one-pot selective C–H oxidation/bromination of ent - 2j′ produced brominated ketone intermediate 44 , from which 46 could be obtained through a one-pot Suzuki/epimerization procedure. Then, a third one-pot transformation, an oxidative cleavage/aldol cyclization, was developed to generate 47 , which incorporates the key [3.3.1] structural framework of lirionol. The first asymmetric synthesis of (+)-lirionol ( 50 ) was then accomplished by several additional simple conversions (Fig. 5). 57 Meanwhile, direct selective benzylic oxidation of ent - 2j’ with Cu catalysis could afford ketone 51 . From this ketone, a compound with the structure reported for aglacin G ( 52 ) was synthesized by means of the protocol illustrated in Fig. 4 for the synthesis of podophyllic aldehyde C ( 26 ), and a compound with the structure reported for aglacin H ( 53 ) was synthesized by a two-step sequence (reduction of the carbonyl groups and selective oxidation of the benzylic alcohol). An aldol reaction of 53 with formaldehyde and subsequent tetrahydrofuran ring formation by a Mitsunobu-type cyclization completed the synthesis of a compound with the structure reported for aglacin D ( 55 ), acid-mediated epimerization of which provided 56 . However, the spectroscopic data for all these synthetic aglacins do not agree with the previously reported data. 58,59 Because our results suggested that the reported syn structures of aglacins D, G, and H were incorrect, we speculated the correct structures had anti configurations and were epimeric at C-7′ (i.e., the same configuration as most other cyclolignans). To confirm this assumption, we carried out some structure revision studies using 2j′ (Fig. 6). A two-step sequence (one-pot oxidation/bromination followed by epimerization) was used to produce intermediate 57 (direct epimerization of 2j′ showed an unsatisfied diastereoselectivity). Reduction of the carbonyl groups with concurrent debromination by LAH were followed by selective oxidation of the benzylic alcohol to afford 58 , the spectroscopic data of which matched the data originally reported for aglacin H. Direct treatment of its MEM acetal derivative with TiCl 4 -DBU in DCM at −20 °C could give the cyclization product 59 , whose spectroscopic data matched the data originally reported for aglacin D. Encouraged by these results, we set out to obtain the correct structures of aglacin G as well. Unfortunately, a direct aldol reaction of genuine aglacin H ( 58 ) under our previously established conditions (Fig. 4, 53 → 54 ) failed, perhaps because of higher steric hindrance in 57 than in previous substrates. Gratifyingly, however, an indirect Mukaiyama aldol reaction by means of Kobayashi’s protocol was successful, and desired hydroxy ketone was obtained in good yield with a diastereoselectivity of 4.8:1. Hydroxy-directed reduction utilizing Evans’ protocol gave desired key diol intermediate 60 . From 60 , we could obtain 61 in good yield via a two-step sequence involving selective oxidative dehydration that afforded the α,β-unsaturated aldehyde and free of the primary alcohol; the spectroscopic data of this compound matched the data originally reported for aglacin G. In addition, lyoniresinol dimethyl ether ( 62 ) was obtained by selective benzylic deoxygenation with concurrent removal of the silyl group from 60 . Subsequent selective demethylation mediated by MgI 2 provided lyoniresinol ( 63 ), while formation of a tetrahydrofuran ring generated aglacin B ( 64 ). The direct oxidation of aglacin B to give aglacins E or F was then investigated, but various benzylic oxidation methods proved unsuccessful in this case. 50 To our delight, the very recent advance by Parasram and co-workers, 60 via exploring the interesting synergistic nature of photoexcited nitroarenes, was found to be possible for this challenging case, and aglacins E ( 65 ) or F ( 66 ) were accessed albeit with poor conversions and low yields. From (+)-aglacin F ( 66 ), (+)-aglacin A ( 67 ) was obtained by simple acetylation. On the other hand, selective tosylation of the primary alcohol of intermediate 60 , and subsequent tetrahydrofuran ring formation triggered by removal of the tert -butyldimethylsilyl group in one pot delivered (+)-aglacin E ( 65 ) in good yield. Its oxidation by PDC afforded ketone 68 . Its reduction by CBS could also provide aglacins E ( 65 ) and F ( 66 ). The first total synthesis of the distinctive cyclolignan ovafolinin D ( 72 ) 61 was also accomplished from hydrogenation product 2k′ . Following the established synthetic sequence for 54 (Fig. 5), its enantiomer ent - 54 could be easily accessed from 2k′ . After that, hydroxy-directed reduction of ent - 54 followed by Lewis acid–promoted cyclization produced 69 , which has one of the tetrahydrofuran rings of ovafolinin D; the absolute configuration of 69 was unambiguously confirmed by X-ray analysis of its ester derivative 70 . The other tetrahydrofuran ring of ovafolinin D was then constructed via radical-initiated oxidative cyclization, and a final selective demethylation achieved by means of MgI 2 completed its first total synthesis. Just as importantly, the current asymmetric hydrogenation protocol is also applicable to tetrasubstituted 1,2-dihydronaphthalene esters readily derivable from 2-tetralones. For instance, subjection of olefin 73 to the standard conditions with ( R , R )-PTBP as the ligand provided the desired hydrogenation product 74 in good results (93% y, 84% ee); this paved the way for the first synthesis of fimbricalyxoid A ( 82 , Fig. 7). 62 Treatment of 74 with p -TSA in a mixture of acetone and water released the aldehyde functionality, which was trapped by phosphorus ylide to give alkene 75 . Epimerization was observed under the Wittig reaction conditions, but this has no influence on the following vinylation. Its vinylation with ethyl Z-3-bromoacrylate delivered diene 76 in good yield. Subsequent ring-closing metathesis (RCM) promoted by a second-generation Grubbs' catalyst completed the construction of the carbon cyclic framework of fimbricalyxoid A to afford 77 . Ensuing ketone formation by a one-pot selective allylic oxidation and followed by the introduction of the two methyl groups furnished key intermediate 78 . Pleasantly, mono-demethylation of 78 was feasible, and the desired phenol 79 was obtained as the major product, while the undesired regioisomer and diphenol could be converted back to 78 though simple methylation. The vinyl group at C-14 was then introduced via Suzuki-Miyaura coupling. Afterwards, conjugate reduction of 80 by modifying a Pd-catalyzed hydrosilylation and ketone protection provided intermediate 81 . 63,64 Finally, ester reduction followed by concurrent demethylation and oxybridge formation via ketone releasement and hemiketal formation, 65 completed the first total synthesis of (+)-fimbricalyxoid A ( 82 ). To conclude, we have developed a powerful new platform for cyclolignan synthesis with ideal modularity and diversity. The syntheses were facilitated by unprecedented Rh-Skewphos-catalyzed enantioselective hydrogenation reactions of dihydronaphthalene tetrasubstituted α,β-unsaturated carboxylic acid esters, which exhibited excellent outcomes (>40 examples; up to 99% y, >99% ee). The generality of this DOS was demonstrated by our syntheses of over 30 cyclolignans, including the first total syntheses of 6-methoxypodophyllotoxin, 6-methoxypodophyllotoxin-7- O -n-hexanoate, cleistantoxin, picrobursenin, austrobailignan-4, aglacins D and F–H, (+)-lirionol, ovafolinin D and fimbricalyxoid A. Subsequent work on de novo DOS of other types of natural products via state-of-the-art asymmetric catalysis, as well as drug development based on the findings of this study, is underway in our laboratory. Declarations Acknowledgements: We are grateful to the National Natural Science Foundation of China (no. 22271236) and the Natural Science Foundation of Zhejiang Province (no. LXZ22B020001) for support of this research. We sincerely thank Professor Thomas J. Schmidt (University of Münster) as well as Professor Young Sook Yun (Tokyo University of Pharmacy and Life Sciences) for kindly providing us their original NMR spectra of 6-methoxypodophyllotoxin-7- O -n-hexanoate and ovafonin D respectively. We acknowledge the Instrumentation and Service Centre for Molecular Sciences at Westlake University for help with measurement and data interpretation. Author contributions: H.H.L. conceived the project, guided the studies, and wrote the manuscript. Z.P. developed the asymmetric hydrogenation and completed the synthesis of podophyllotoxins and related cyclolignans. W.X.X completed the syntheses of (+)-lirionol, aglacins, ovafolinin D and fimbricalyxoid A. Q.X.G., Y.Z. and L.H.Z. helped with the preparation of some intermediates. All the authors contributed to the analysis and interpretation of the results. Supplementary Information: • Experimental procedures and characterization data for all new compounds • NMR and HPLC spectra for all for all new compounds • X-ray data for compounds 2p , 9 , 16 , 47 , and 70 Competing interests: The authors declare no competing financial interests. References Shen, B. A new golden age of natural products drug discovery. Cell 163 , 1297–1300 (2015). Rodrigues, T. et al. Counting on natural products for drug design. Nat. Chem. 8 , 531–541 (2016). Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 83 , 770-803 (2020). Wright, P. M., Seiple, I. B. & Myers, A. G. The evolving role of chemical synthesis in antibacterial drug discovery. Angew. Chem. Int. Ed. 53 , 8840–8869 (2014). Allred, T. K.; Manoni, F. & Patrick G. Harran, Exploring the boundaries of “practical”: de novo syntheses of complex natural product-based drug candidates. Chem. Rev. 117 , 11994–1205 (2017). Schreiber, S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287 , 1964–1969 (2000). Li, L.; Chen, Z.; Zhang, X. & Jia, Y. Divergent strategy in natural product total synthesis. Chem. Rev. 118 , 3752–3832 (2018). Charest, M. G.; Lerner, C. D.; Brubaker, J. D.; Siegel, D. R. & Myers, A. G. A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics. Science 308 , 395–398 (2005). Seiple, I. B. et al. A platform for the discovery of new macrolide antibiotics. Nature 533 , 338–345 (2016). Li, Q. et al. Synthetic group A streptogramin antibiotics that overcome Vat resistance. Nature 586 , 145–150 (2020). Mitcheltree, M. J. et al. A synthetic antibiotic class overcoming bacterial multidrug resistance. Nature 599 , 507–512 (2021). Smith, P. A. et al. Optimized arylomycins are a new class of Gram-negative antibiotics. Nature 651 , 189–194 (2018). Murphy, S. K.; Zeng, M. & Herzon, S. B. A modular and enantioselective synthesis of the pleuromutilin antibiotics. Science 356 , 956–959 (2017). Wang, X. et al. A radical cascade enabling collective syntheses of natural products. Chem 2 , 803–816 (2017). Zhang, X. et al. Divergent synthesis of complex diterpenes through a hybrid oxidative approach. Science 369 , 799–806 (2020). Harwood, S. J. et al. Modular terpene synthesis enabled by mild electrochemical couplings. Science 375 , 745–752 (2022). Scharf, M. J. & List, B. A catalytic asymmetric Pictet-Spengler platform as a biomimetic diversification strategy toward naturally occurring alkaloids. J. Am. Chem. Soc. 144 , 15451–15456 (2022). Goethe, O.; DiBello, M. & Herzon, S. B. Total synthesis of structurally diverse pleuromutilin antibiotics. Nat. Chem. 14 , 1270–1277 (2022). Bruno, B.; Giulliano Delle, M.; Domenico, M.; Alberto, V. & Giovanni, Z. Aryltetralin lignans: chemistry, pharmacology and biotransformations. Curr. Med. Chem. 8 , 1363-1381 (2001). Vassão, D. G.; Kim, K.-W.; Davin, L. B. & Lewis, N. G. Lignans (neolignans) and allyl/propenyl phenols: biogenesis, structural biology, and biological/human health considerations. In Comprehensive Natural Products II ; H.-W. Liu & L. Mander Eds.; Elsevier, pp. 815–928 (2010). Shah, Z. et al. Podophyllotoxin: History, recent advances and future prospects, Biomolecules 11 , 603–630 (2021). Yu, X.; Che, Z. & Xu, H. Recent advances in the chemistry and biology of podophyllotoxins. Chem. Eur. J. 23 , 4467–4526 (2017). Zhao, W. et al. Challenges and Potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy. Nat. Prod. Rep. 38 , 470–488 (2021). Reynolds, R. G.; Nguyen, H. Q. A.; Reddel, J. C. T. & Thomson, R. J. Recent strategies and tactics for the enantioselective total syntheses of cyclolignan natural products. Nat. Prod. Rep. 39 , 670–702 (2022). Fang, X. & Hu, X. Advances in the synthesis of lignan natural products. Molecules 23 , 3385 (2018). Reddel, J. C. T.; Lutz, K. E.; Diagne, A. B. & Thomson, R. J. Stereocontrolled syntheses of tetralone and naphthyl-type lignans by a one-pot oxidative [3,3] rearrangement/Friedel–Crafts arylation, Angew. Chem. Int. Ed. 53 , 1395–1398 (2014). Ting, C. P. & Maimone, T. J. C-H Bond arylation in the synthesis of aryltetralin lignans: A short total synthesis of podophyllotoxin. Angew. Chem. Int. Ed. 53 , 3115–3119 (2014). Hajra, S.; Garai, S. & Hazra, S. Catalytic enantioselective synthesis of (-)-podophyllotoxin. Org. Lett. 19 , 6530–6533 (2017). Xiao, J.; Cong, X.-W.; Yang, G.-Z.; Wang, Y.-W. & Peng, Y. Divergent asymmetric syntheses of podophyllotoxin and related family members via stereoselective reductive Ni-catalysis. Org. Lett. 20 , 1651–1654 (2018). Li, J.; Zhang, X. & Renata, H. Asymmetric Chemoenzymatic Synthesis of (-)-Podophyllotoxin and Related Aryltetralin Lignans. Angew. Chem. Int. Ed. 58 , 11657–11660 (2019). Lazzarotto, M. et al. Chemoenzymatic total synthesis of deoxy-, epi -, and podophyllotoxin and a biocatalytic kinetic resolution of dibenzylbutyrolactones. Angew. Chem. Int. Ed. 58 , 8226–8230 (2019). Xiang, J-C.; Wang, Q. & Zhu, J. Radical-cation cascade to aryltetralin cyclic ether lignans under visible-light photoredox catalysis. Angew. Chem. Int. Ed. 59 , 21195–21202 (2020). Xu, M.; Hou, M.; He, H. & Gao, S. Asymmetric total synthesis of aglacins A, B, and E. Angew. Chem. Int. Ed. 60 , 16655–16660 (2021). Cao, M.-Y. et al. Optically active flavaglines-inspired molecules by a palladium-catalyzed decarboxylative dearomative asymmetric allylic alkylation. J. Am. Chem. Soc. 142 , 12039–12045 (2020). Cao, M.-Y.; Ma, B.-J.; Gu, Q.-X.; Fu, B. & Lu, H.-H. Concise enantioselective total synthesis of daphenylline enabled by an intramolecular oxidative dearomatization. J. Am. Chem. Soc. 144 , 5750–5755 (2022). For a lead perspective, see: Kraft, S.; Ryan, K. & Kargbo, R. B. Recent advances in asymmetric hydrogenation of tetrasubstituted olefins. J. Am. Chem. Soc. 139 , 11630–11641 (2017). Song, S.; Zhu, S.-F.; Li, Y. & Zhou, Q.-L. Iridium-catalyzed enantioselective hydrogenation of α,β-unsaturated carboxylic acids with tetrasubstituted olefins, Org. Lett. 15 , 3722–3725 (2013). Du, X. et al. Enantioselective hydrogenation of tetrasubstituted α,β-unsaturated carboxylic acids enabled by cobalt(II) catalysis: scope and mechanistic insights, Angew. Chem. Int. Ed. 60 , 11384–11390 (2021). Chen, G.-Q. et al. Highly Enantioselective hydrogenation of tetra - and tri -substituted α,β-unsaturated carboxylic acids with oxa -spiro diphosphine ligands. CCS chem. 2 , 468–477 (2020). Molinaro, C. et al. A practical synthesis of renin inhibitor MK-1597 (ACT-178882) via catalytic enantioselective hydrogenation and epimerization of piperidine intermediate. J. Org. Chem. 76 , 1062–1071 (2011). Christensen, M. et al. Enantioselective synthesis of α-methyl-β-cyclopropyldihydrocinnamates. J. Org. Chem. 81 , 824–830 (2016). Kerdphon, S. et al. Diastereo- and enantioselective synthesis of structurally diverse succinate, butyrolactone, and trifluoromethyl derivatives by Iridium-catalyzed hydrogenation of tetrasubstituted olefins. ACS Catal. 9 , 6169−6176 (2019). Troutman, M. V.; Appella, D. H. & Buchwald, S. L. Asymmetric hydrogenation of unfunctionalized tetrasubstituted olefins with a cationic zirconocene catalyst, J. Am. Chem. Soc. 121 , 4916–4917 (1999). Schrems, M. G.; Neumann, E. & Pfaltz, A. Iridium-catalyzed asymmetric hydrogenation of unfunctionalized tetrasubstituted olefins. Angew. Chem. Int. Ed. 46 , 8274–8276 (2007). Zanotti-Gerosa, A.; Gazić Smilović, I. & Časar, Z. Acid promoted Ir–P^N complex catalyzed hydrogenation of heavily hindered 3,4-diphenyl-1,2-dihydronaphthalenes: asymmetric synthesis of lasofoxifene tartrate, Org. Chem. Front. 4 , 2311–2322 (2017). Biosca, M. et al. Extending the substrate scope in the hydrogenation of unfunctionalized tetrasubstituted olefins with Ir-P stereogenic aminophosphine-oxazoline Catalysts. Org. Lett. 21 , 807–811 (2019). Zhang, Z.; Zhu, G.; Jiang, Q.; Xiao, D. & Zhang, X. Highly Enantioselective Hydrogenation of Cyclic Enamides Catalyzed by a Rh-PennPhos Catalyst. J. Org. Chem. 64 , 1774–1775 (1999). Yue, T.-Y. & Nugent, W. A. Enantioselective hydrogenation of 3-alkylidenelactams: high-throughput screening provides a surprising solution. J. Am. Chem. Soc. 124 , 13692–13693 (2002). Lu, S. & Alper, H. Sequence of intramolecular carbonylation and asymmetric hydrogenation reactions: highly regio- and enantioselective synthesis of medium ring tricyclic lactams. J. Am. Chem. Soc. 130 , 6451–6455 (2008). Lubov, D. P.; Talsi, E. P. & Bryliakov, K. P. Methods for selective benzylic C–H oxofunctionalization of organic compounds. Russ. Chem. Rev. 89 , 587–628 (2020). Lawrence, N. J.; Drew, M. D. & Bushell, S. M. Polymethylhydrosiloxane: a versatile reducing agent for organic synthesis. J. Chem. Soc., Perkin Trans. 1 , 3381–3391 (1999). Previous efforts to synthesize this cyclolignan were reported to be unsuccessful, see: Forsey, S. P.; Rajapaksa, D.; Taylor, N. J. & Rodrigo, R. Comprehensive synthetic route to eight diastereomeric podophyllum lignans. J. Org. Chem. 54 , 4280–4290 (1989). Klaes, M.; Ellendorff, T; Schmidt, T.-S. 6-Methoxypodophyllotoxin-7- O -n-hexanoate, a new aryltetralin lignan ester from seeds of Linum flavum . Planta Med. 76 , 719–721 (2010). Thanh, V. T. T.; Pham, V.-C.; Mai, H.-D. T.; Litaudon, M.; Gueritte, F.; Retailleau, P.; Nguyen, V. H.; Chau, V. M. J. Cytotoxic lignans from fruits of Cleistanthus indochinensis : synthesis of cleistantoxin derivatives. J. Nat. Prod. 75 , 1578–1583 (2012). Thanh, V. T. T.; Pham, V.-M.; Mai, H. D. T.; Litaudon, M.; Guéritte, F.; Nguyen, V.-H.; Chau, V. M. Cytotoxic aryltetralin lignans from fruits of Cleistanthus indochinensis . Planta Med. 80 , 695–702 (2014). Its spectroscopic data does not agree with the previously reported data, which we found to agree well with deoxypodophyllotoxin 11 , see: Kuo, Y.-H.; Yu, M.-T. A new lignan, formosalactone, from the bark of Juniperus formosana Hay. var. concolor Hay. Heterocycles 36 , 529–535 (1993). Weeratunga, G. Rajapaksa, D. & Rodrigo, R. The synthesis and relative configuration of (±)-lirionol. J. Org. Chem. 50 , 5902–5905 (1985). Wang, B.-G. et al. Aglacins A-D, first representatives of a new class of aryltetralin cyclic ether lignans from Aglaia cordata . J. Nat. Prod. 64 , 1521–1526 (2001). Wang, B.-G.; Ebel, R.; Wang, C.-Y.; Wray, V. & Proksch, P. New methoxylated aryltetrahydronaphthalene lignans and a norlignan from Aglaia cordata . Tetrahedron Lett. 43 , 5783–5787 (2002). Paolillo, J. M.; Duke, A. D.; Gogarnoiu, E. S.; Wise, D. E. & Parasram, M. Anaerobic hydroxylation of C(sp 3 )–H bonds enabled by the synergistic nature of photoexcited nitroarenes. J. Am. Chem. Soc. 145 , 2794–2799 (2023). Kashima, K. et al. Ovafolinins A-E, five new lignans from Lyonia ovalifolia . Chem. Pharm. Bull. 58 , 191–194 (2010). Chao, C.-H. et al. Terpenoids from Flueggea virosa and their anti-hepatitis C virus activity. Phytochemistry 128 , 60–70 (2016). Zhang, P. et al. A neural network model informs the total synthesis of clovane sesquiterpenoids. Nat. Synth. DOI: 10.1038/s44160-023-00271-0 (2023). Benohoud, M.; Tuokko, S. & Pihko, P. M. Stereoselective hydrosilylation of enals and enones catalysed by palladium nanoparticles. Chem. Eur. J. 17 , 8404–8413 (2011). Li, L.-P. et al. Total synthesis of the alleged structure of (+)-fimbricalyxoid A. Org. Lett. 24 , 3477–3481 (2022). Additional Declarations There is NO Competing Interest. Supplementary Files SupplementaryInformation.pdf SI TOC.jpg Cite Share Download PDF Status: Published Journal Publication published 20 Jun, 2024 Read the published version in Nature Synthesis → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-2924400","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Physical Sciences - Article","associatedPublications":[],"authors":[{"id":202089236,"identity":"7a488afb-a86e-41bd-9cba-fa60d94bb3b9","order_by":0,"name":"Wen-Xiu Xu","email":"","orcid":"","institution":"Westlake University","correspondingAuthor":false,"prefix":"","firstName":"Wen-Xiu","middleName":"","lastName":"Xu","suffix":""},{"id":202089237,"identity":"67317f64-18e9-4581-9815-c7b47ec4e384","order_by":1,"name":"Zhuo Peng","email":"","orcid":"","institution":"Westlake University","correspondingAuthor":false,"prefix":"","firstName":"Zhuo","middleName":"","lastName":"Peng","suffix":""},{"id":202089238,"identity":"65f4efcf-2375-4f49-9f2b-398ca9c95215","order_by":2,"name":"Qing-Xiu Gu","email":"","orcid":"","institution":"Westlake University","correspondingAuthor":false,"prefix":"","firstName":"Qing-Xiu","middleName":"","lastName":"Gu","suffix":""},{"id":202089239,"identity":"1a666579-a086-4cb7-9c4a-3b576534019a","order_by":3,"name":"Yao Zhu","email":"","orcid":"","institution":"Westlake University","correspondingAuthor":false,"prefix":"","firstName":"Yao","middleName":"","lastName":"Zhu","suffix":""},{"id":202089240,"identity":"8b38f840-6e4e-42f5-88f0-68cf6edb26ea","order_by":4,"name":"Li-Han Zhao","email":"","orcid":"","institution":"Westlake University","correspondingAuthor":false,"prefix":"","firstName":"Li-Han","middleName":"","lastName":"Zhao","suffix":""},{"id":202089241,"identity":"bf7cb6e0-3770-4786-8e10-aec246ba501a","order_by":5,"name":"Hai-Hua Lu","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA/klEQVRIiWNgGAWjYBACPgYeBobEBgYGfjC3gMEAREng08IG0yIJxAwHDIjVwghUbnCAaC0SuQc/PNxxWN74RvLhzx8M7Iz5GZgP3uZhsMvDrSUvWSLxzGHDbTfS0iQOGCSbSTawJVvzMCQX49aSYyCR2HaYcdvtHDOgw5htDA7wmEnzMBwAeRCXFuMfQC32m2fnf/5wwKDexv4A/zdCWsxAtiRukM5hADrssJkBAw8bfi08b8wsEtvSk2fcf2YmccbguLHEYTZjyzkGyTi18LPnGN/82WZt299z+PGHiopqw/725oc33lTY4dSCBTCDCAPi1Y+CUTAKRsEowAQAh7dT/n9+YSEAAAAASUVORK5CYII=","orcid":"https://orcid.org/0000-0003-3604-7145","institution":"Westlake University","correspondingAuthor":true,"prefix":"","firstName":"Hai-Hua","middleName":"","lastName":"Lu","suffix":""}],"badges":[],"createdAt":"2023-05-11 21:12:18","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-2924400/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-2924400/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s44160-024-00564-y","type":"published","date":"2024-06-20T04:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":49327596,"identity":"24cd0b51-f3d0-4795-ae2b-9dccaf2f73c8","added_by":"auto","created_at":"2024-01-08 17:43:30","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":675267,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eStrategies for the DOS of cyclolignans. a–e\u003c/strong\u003e, Representative previously reported DOS strategies for the synthesis of cyclolignans. \u003cstrong\u003ef\u003c/strong\u003e, Unified design for cyclolignan synthesis by asymmetric hydrogenation of tetrasubstituted olefins derived from readily available 1-tetralones (this work). \u003cstrong\u003eg\u003c/strong\u003e, Previously reported asymmetric hydrogenation reactions of 1,2-dihydronaphthalene tetrasubstituted olefins.\u003c/p\u003e","description":"","filename":"1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-2924400/v1/fc1c7b5190dbd704cb9f3b27.jpg"},{"id":49327039,"identity":"c52a2a9d-7f57-4f53-b364-6264a629bfae","added_by":"auto","created_at":"2024-01-08 17:35:30","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":698752,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eScope of the Rh-catalyzed asymmetric hydrogenation of dihydronaphthalene α,β-unsaturated carboxylic acid esters. \u003c/strong\u003eUnless otherwise noted, reactions were conducted with \u003cstrong\u003e1\u003c/strong\u003e (0.10 mmol), Rh(COD)\u003csub\u003e2\u003c/sub\u003eBAr\u003csup\u003eF\u003c/sup\u003e\u003csub\u003e4\u003c/sub\u003e (1.0 mol%), and (\u003cem\u003eR\u003c/em\u003e,\u003cem\u003eR\u003c/em\u003e)-BDPP (1.2 mol%) in DCM under H\u003csub\u003e2\u003c/sub\u003e (40 bar) at 40 °C for 36 h (Isolated yields are reported, and ee values were determined by chiral HPLC or SFC). \u003csup\u003e\u003cem\u003ea\u003c/em\u003e\u003c/sup\u003e2 mol% of Rh(COD)\u003csub\u003e2\u003c/sub\u003eBAr\u003csup\u003eF\u003c/sup\u003e\u003csub\u003e4\u003c/sub\u003e and 2.4 mol% of (\u003cem\u003eR\u003c/em\u003e,\u003cem\u003eR\u003c/em\u003e)-BDPP were used. \u003csup\u003e\u003cem\u003eb\u003c/em\u003e\u003c/sup\u003e4 mol% of Rh(COD)\u003csub\u003e2\u003c/sub\u003eBAr\u003csup\u003eF\u003c/sup\u003e\u003csub\u003e4\u003c/sub\u003e and 4.8 mol% of (\u003cem\u003eR\u003c/em\u003e,\u003cem\u003eR\u003c/em\u003e)-BDPP were used. \u003csup\u003e\u003cem\u003ec\u003c/em\u003e\u003c/sup\u003e6 mol% of Rh(COD)\u003csub\u003e2\u003c/sub\u003eBAr\u003csup\u003eF\u003c/sup\u003e\u003csub\u003e4\u003c/sub\u003e and 7.2 mol% of (\u003cem\u003eR\u003c/em\u003e,\u003cem\u003eR\u003c/em\u003e)-BDPP were used. \u003csup\u003e\u003cem\u003ed\u003c/em\u003e\u003c/sup\u003eResults obtained from a gram- or multigram-scale reaction. \u003csup\u003e\u003cem\u003ee\u003c/em\u003e\u003c/sup\u003eConducted at 60 °C. COD = cyclooctadiene; Ar\u003csup\u003eF\u003c/sup\u003e = 3,5-bis(trifluoromethyl)phenyl; BDPP = 2,4-bis(diphenylphosphino)-pentane; y = yield; ee = enantiomeric excess.\u003c/p\u003e","description":"","filename":"2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-2924400/v1/963025420a2771dced84348a.jpg"},{"id":49327845,"identity":"57678421-6aaf-4dac-9812-b0a3fb6e57d9","added_by":"auto","created_at":"2024-01-08 17:51:30","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":566150,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eTotal syntheses of podophyllotoxins. a\u003c/strong\u003e, Divergent total syntheses of podophyllone (\u003cstrong\u003e8\u003c/strong\u003e), (−)-PPT (\u003cstrong\u003e10\u003c/strong\u003e), deoxypodophyllotoxin (\u003cstrong\u003e11\u003c/strong\u003e), deoxypicropodophyllotoxin (\u003cstrong\u003e12\u003c/strong\u003e), austrobailignan-4 (\u003cstrong\u003e14\u003c/strong\u003e), isopicropodophyllone (\u003cstrong\u003e15\u003c/strong\u003e), epiisopicropodophyllotoxin (\u003cstrong\u003e16\u003c/strong\u003e), and deoxyepiisopicropodophyllotoxin (\u003cstrong\u003e17\u003c/strong\u003e) from \u003cstrong\u003e2p\u003c/strong\u003e. \u003cstrong\u003eb\u003c/strong\u003e, Syntheses of β-peltatin-A-methyether (\u003cstrong\u003e18\u003c/strong\u003e), 6-methoxypodophyllotoxin (\u003cstrong\u003e19\u003c/strong\u003e), 6-methoxypodophyllotoxin-7-\u003cem\u003eO\u003c/em\u003e-n-hexanoate (\u003cstrong\u003e20\u003c/strong\u003e), cleistantoxin (\u003cstrong\u003e21\u003c/strong\u003e), and picrobursenin (\u003cstrong\u003e22\u003c/strong\u003e) from \u003cstrong\u003e2k’\u003c/strong\u003e or \u003cstrong\u003e2l’\u003c/strong\u003e.\u003cstrong\u003e \u003c/strong\u003e3,5-DMP = 3,5-dimethylpyrazole; NHPI = N-hydroxyphthalimide; 4CzIPN = 1,2,3,5-tetrakis(carbazol-9-yl)-4,6-dicyanobenzene; TMEPO = 2,2,6,6-tetramethylpiperidine 1-oxyl; PMHS = polymethylhydrosiloxane; TFE = 2,2,2-trifluoroethanol; LAH = lithium aluminum hydride.\u003c/p\u003e","description":"","filename":"3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-2924400/v1/c439c6fc9d50c43978d78745.jpg"},{"id":49327036,"identity":"a350cfcd-3d86-41d3-bcdd-eab3fd394dcd","added_by":"auto","created_at":"2024-01-08 17:35:30","extension":"jpg","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":654391,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eSynthesis of other types of cyclolignans via epimerization of 2p. \u003c/strong\u003eDIPEA = diisopropylethylamine; EDCI = 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride; DMAP = 4-(dimethylamino)pyridine; TPAP = tetrapropylammonium perruthenate; NMO = 4-methylmorpholine N-oxide; LHMDS = lithium bis(trimethylsilyl)amide; DIBAL = diisobutylaluminum hydride; \u003cem\u003ep\u003c/em\u003e-TSA = \u003cem\u003ep\u003c/em\u003e-toluenesulfonic acid.\u003c/p\u003e","description":"","filename":"4.jpg","url":"https://assets-eu.researchsquare.com/files/rs-2924400/v1/68f273018f27a6630ea1635a.jpg"},{"id":49327042,"identity":"72a23c43-9699-4b66-a355-91fbb7879c41","added_by":"auto","created_at":"2024-01-08 17:35:30","extension":"jpg","order_by":5,"title":"Figure 5","display":"","copyAsset":false,"role":"figure","size":508954,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eThe first asymmetric total syntheses (+)-lirionol (50) and compounds (52, 53 amd 55) with the structures reported for aglacins D, G, and H from \u003c/strong\u003e\u003cem\u003e\u003cstrong\u003eent\u003c/strong\u003e\u003c/em\u003e\u003cstrong\u003e-2j\u003c/strong\u003e′\u003cstrong\u003e.\u003c/strong\u003e DBU = 1,8-diazabicyclo(5.4.0)undec-7-ene; dppf = 1,1′-ferrocenediyl-bis(diphenylphosphine); TBHP = \u003cem\u003etert\u003c/em\u003e-butyl hydroperoxide; NBS = N-bromosuccinimide; LTMP = lithium tetramethylpiperidide; DBAD = dibenzyl azodicarboxylate.\u003c/p\u003e","description":"","filename":"5.jpg","url":"https://assets-eu.researchsquare.com/files/rs-2924400/v1/87d59a6b6b0abdf45b26ac3c.jpg"},{"id":49327597,"identity":"4537c960-914e-4497-8b88-a458f9b653cb","added_by":"auto","created_at":"2024-01-08 17:43:30","extension":"jpg","order_by":6,"title":"Figure 6","display":"","copyAsset":false,"role":"figure","size":824483,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eTotal syntheses of the correct structures of aglacins A, B, and D–G; lyoniresinol and its dimethyl ether; ovafolinin D; from 2j’. \u003c/strong\u003eMEMCl = 2-methoxyethoxymethyl chloride; NCS = \u003cem\u003eN\u003c/em\u003e-chlorosuccinimide; TBAC = tetrabutylammonium chloride; (\u003cem\u003eS\u003c/em\u003e)-Me-CBS = (\u003cem\u003eS\u003c/em\u003e)-2-methyl-CBS-oxazaborolidine.\u003c/p\u003e","description":"","filename":"6.jpg","url":"https://assets-eu.researchsquare.com/files/rs-2924400/v1/c4bd7556f04fcdb84b333539.jpg"},{"id":49327037,"identity":"626a4965-d99b-48b2-8b49-b1d97814afd0","added_by":"auto","created_at":"2024-01-08 17:35:30","extension":"jpg","order_by":7,"title":"Figure 7","display":"","copyAsset":false,"role":"figure","size":403280,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eThe first total synthesis of fimbricalyxoid A (82).\u003c/strong\u003e PTBP = pentane-2,4-diylbis(bis(4-(\u003cem\u003etert\u003c/em\u003e-butyl)phenyl)phosphine); Grubbs II = (1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium; DMP = Dess-Martin periodinane or 1,1,1-tris(acetyloxy)-1,1-dihydro-1,2-benziodoxol-3-(1H)-one; BrettPhos = 2-(dicyclohexyl-phosphino)3,6-dimethoxy-2′,4′,6′-triisopropyl-1,1′-biphenyl.\u003c/p\u003e","description":"","filename":"7.jpg","url":"https://assets-eu.researchsquare.com/files/rs-2924400/v1/5885b8a1d2573695ed4ed188.jpg"},{"id":58789879,"identity":"f80505f2-46e6-42c9-9485-3bf276513155","added_by":"auto","created_at":"2024-06-21 07:06:17","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":5107735,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-2924400/v1/9be81c80-4dbc-4d9a-a984-f4ee4d9bee18.pdf"},{"id":49327044,"identity":"08d9428b-8efd-4737-813d-789989accf09","added_by":"auto","created_at":"2024-01-08 17:35:31","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":17807018,"visible":true,"origin":"","legend":"SI","description":"","filename":"SupplementaryInformation.pdf","url":"https://assets-eu.researchsquare.com/files/rs-2924400/v1/2b0b77679be66f7a9e611c89.pdf"},{"id":49327040,"identity":"e9d0eb65-8032-48bf-8735-d33985cd8cbb","added_by":"auto","created_at":"2024-01-08 17:35:30","extension":"jpg","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":286433,"visible":true,"origin":"","legend":"","description":"","filename":"TOC.jpg","url":"https://assets-eu.researchsquare.com/files/rs-2924400/v1/6975bfaae648ebaf09ab8ee7.jpg"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Cyclolignan Synthesis Streamlined by Enantioselective Hydrogenation of Tetrasubstituted Olefins","fulltext":[{"header":"Main Text","content":"\u003cp\u003eCyclolignans also known as aryltetralins, are a family of miscellaneous lignan natural products that are found in many plant species and that display intriguing structural diversity and biological activities (such as anticancer, anti-tubulin polymerization, antiviral, antibacterial, antineoplastic, cytotoxic, and antimalarial activities).\u003csup\u003e19,\u003c/sup\u003e\u003csup\u003e20\u003c/sup\u003e For example, podophyllotoxin (PPT),\u003csup\u003e21 \u003c/sup\u003eone of the most well-known cyclolignans, shows exceptional cytotoxicity to a variety of cancer cell lines through binding to the colchicine site of the tubulin subunit and thus inhibiting microtubule assembly. Accordingly, PPT has for decades been the focus of chemical synthesis and the development of related anticancer drugs.\u003csup\u003e22,23\u003c/sup\u003e Considerable structural modification of PPT has led to numerous derivatives with activities against various types of cancers, and several derivatives are currently in clinical use, including the DNA-topoisomerase II inhibitors teniposide and etoposide (which is on the WTO\u0026rsquo;s list of essential medicines).\u003csup\u003e \u003c/sup\u003eUnfortunately, the therapeutic potential of PPT derivatives is often hampered by their poor bioavailability and the development of drug resistance. In addition, subtle changes in the aromatic rings of the parent PPT scaffold have been reported to dramatically influence their inhibitory activities. Tackling these issues will require that inherently exhaustible classical semisynthetic derivatization approaches to cyclolignans, which rely heavily on natural sources and are handicapped by the inflexible structural features of such sources, be supplemented with more powerful, diversity-oriented de novo strategies.\u003csup\u003e24,25\u003c/sup\u003e\u003c/p\u003e\n\u003cp\u003eIn 2014, Thomson and coworkers reported diversity-oriented synthesis (DOS) of six cyclolignans by means of novel tandem stereoselective oxidative [3,3]-sigmatropic rearrangement/Friedel-Crafts arylation reactions between electron-rich arenes and \u003cem\u003eN\u003c/em\u003e-allylhydrazones (Fig. 1a),\u003csup\u003e26\u003c/sup\u003e and Maimone and Ting reported DOS of PPT and some 7\u0026rsquo;-aryl analogs via elegant Pd-catalyzed C(sp\u003csup\u003e3\u003c/sup\u003e)\u0026ndash;H arylation reactions (Fig. 1b).\u003csup\u003e27\u003c/sup\u003e These pioneering studies provoked further exploration of divergent syntheses of cyclolignans.\u003csup\u003e28-33\u003c/sup\u003e Recently, the groups of Renata,\u003csup\u003e30\u003c/sup\u003e and Kroutil, Fuchs and colleagues\u003csup\u003e31\u003c/sup\u003e independently reported the intriguing chemoenzymatic total syntheses of (\u0026minus;)-PPT and a few related lactone cyclolignans by means of a nonheme dioxygenase 2-ODD-PH-catalyzed intramolecular oxidative cyclizations (Fig. 1c). Meanwhile, Zhu and coworkers developed a method for unusual radical-cation cascade reactions of dicinnamyl ethers that involved visible-light photoredox catalysis to facilitate concise, diastereoselective syntheses of several cyclic ether cyclolignans (Fig. 1d).\u003csup\u003e32\u003c/sup\u003e More recently, Gao and coworkers achieved asymmetric total syntheses of cyclic ether cyclolignans aglacins A, B, and E via interesting chiral Ti-mediated photoenolization/Diels\u0026ndash;Alder reactions between electron-rich 2-methylbenzaldehydes and unsaturated \u0026gamma;-lactones (Fig. 1e).\u003csup\u003e33\u003c/sup\u003e Motivated by these impressive advances and coupled with our continuing interest in natural products as leads for drug development by de novo\u003cem\u003e \u003c/em\u003eDOS,\u003csup\u003e34\u003c/sup\u003e we embarked on a search for a far more general platform for cyclolignan synthesis with the hope of achieving ideal modularity and diversity.\u003c/p\u003e\n\u003cp\u003eCognizant of the fact that cyclolignans share a common feature: the aryl substituent at C-7\u0026prime; is either \u003cem\u003esyn\u003c/em\u003e- or \u003cem\u003eanti\u003c/em\u003e- to the substituent at C-8\u0026prime;,\u003csup\u003e19-25\u003c/sup\u003e we conjectured that the asymmetric hydrogenation of 1,2-dihydronaphthalene tetrasubstituted olefins \u003cstrong\u003e1\u003c/strong\u003e as information-rich hidden retrons,\u003csup\u003e35\u003c/sup\u003e comprising the vital scaffold and functionalities of cyclolignans and have a deliberately installed ester group to serve as a handle for subsequent epimerization and other manipulations, might provide a universal platform for cyclolignan synthesis (Fig. 1f). In addition, we expected that olefins \u003cstrong\u003e1\u003c/strong\u003e would be easily accessible from readily available 1-tetralones. However, we also envisioned the pivotal asymmetric hydrogenation of the tetrasubstituted olefins \u003cstrong\u003e1 \u003c/strong\u003eto present a paramount challenge; as work on hydrogenation of tetrasubstituted olefins has progressed relatively slowly and appears to be rather limited,\u003csup\u003e36-39\u003c/sup\u003e in marked contrast to di- and trisubstituted olefins. Furthermore, to the best of our knowledge, there have been only a few studies, with limited success, on hydrogenation of simple unfunctionalized or non-activated tetrasubstituted \u0026alpha;,\u0026beta;-unsaturated carboxylic acid esters; and the reported instances all require chiral Ru or Ir catalysis.\u003csup\u003e40-42\u003c/sup\u003e\u003c/p\u003e\n\u003cp\u003eAsymmetric hydrogenation of unfunctionalized 1,2-dihydronaphthalene tetrasubstituted olefins (e.g., \u003cstrong\u003e3a\u003c/strong\u003e and \u003cstrong\u003e3b\u003c/strong\u003e) was pioneered by Buchwald and coworkers,\u003csup\u003e43\u003c/sup\u003e who used a highly active chiral Zr catalyst, and was later investigated by the groups of Pfaltz\u003csup\u003e44\u003c/sup\u003e and others,\u003csup\u003e45-46\u003c/sup\u003e who frequently used more practical chiral Ir or Ru catalysts; almost concurrently, Zhang and coworkers\u003csup\u003e47\u003c/sup\u003e reported the first and only example of amino-functionalized olefin \u003cstrong\u003e5\u003c/strong\u003e utilizing a chiral Rh-PennPhos Catalyst (Fig. 1g). However, good reactivities and enantiomeric outcomes were observed for only a handful of 1,2-dihydronaphthalene tetrasubstituted olefins with these catalysts. Indeed, we found asymmetric hydrogenation of the desired dihydronaphthalene-based tetrasubstituted olefins bearing an ester group (\u003cstrong\u003e1\u003c/strong\u003e) to be very challenging (see Supplementary Information for detailed optimization data). After considerable investigation, we finally succeeded with the aid of a powerful new chiral Rh catalyst generated in situ\u003cem\u003e \u003c/em\u003efrom a combination of Rh(COD)\u003csub\u003e2\u003c/sub\u003eBAr\u003csup\u003eF\u003c/sup\u003e\u003csub\u003e4\u003c/sub\u003e and relatively less hindered (\u003cem\u003eR\u003c/em\u003e,\u003cem\u003eR\u003c/em\u003e) or (\u003cem\u003eS\u003c/em\u003e,\u003cem\u003eS\u003c/em\u003e)-BDPP as a ligand (Fig. 2). Notably, to our knowledge, this represents the first successful application of Skewphos for enantioselective hydrogenation of tetrasubstituted olefins.\u003csup\u003e48,49\u003c/sup\u003e\u003c/p\u003e\n\u003cp\u003eThis new chiral Rh catalyst generally afforded excellent results (Fig. 2). We began by evaluating olefins with various substituents at C-7\u0026prime; (\u003cstrong\u003e2a\u003c/strong\u003e\u0026ndash;\u003cstrong\u003ev\u003c/strong\u003e). The reactions of all the substrates with aromatic substituents (\u003cstrong\u003e2a\u003c/strong\u003e\u0026ndash;\u003cstrong\u003es\u003c/strong\u003e) proceeded smoothly and gave excellent results, regardless of the steric or electronic properties of their \u003cem\u003eortho\u003c/em\u003e, \u003cem\u003emeta\u003c/em\u003e, and \u003cem\u003epara\u003c/em\u003e substituents (90\u0026ndash;99% y and 90\u0026ndash;99% ee). Pleasingly, olefins with a vinyl (\u003cstrong\u003e1t\u003c/strong\u003e) or an alkyl substituent (\u003cstrong\u003e1u\u003c/strong\u003e and \u003cstrong\u003e1v\u003c/strong\u003e) were also suitable, giving hydrogenation products \u003cstrong\u003e2t\u003c/strong\u003e\u0026ndash;\u003cstrong\u003ev\u003c/strong\u003e with excellent outcomes (95\u0026ndash;99% y and 90\u0026ndash;95% ee). Next, we examined substrates with various substituents on the dihydronaphthalene ring (\u003cstrong\u003e2w\u003c/strong\u003e\u0026ndash;\u003cstrong\u003eo\u0026prime;\u003c/strong\u003e). To our delight, substrates with a single electron-withdrawing or electron-donating \u003cem\u003epara \u003c/em\u003esubstituent gave excellent results (\u003cstrong\u003e2w\u003c/strong\u003e\u0026ndash;\u003cstrong\u003ec\u0026prime;\u003c/strong\u003e, 90\u0026ndash;97% y and 96\u0026ndash;99% ee). Moreover, substrates with a \u003cem\u003emeta \u003c/em\u003e(\u003cstrong\u003e1d\u0026prime;\u003c/strong\u003e and \u003cstrong\u003e1e\u0026prime;\u003c/strong\u003e)\u003cem\u003e \u003c/em\u003eor \u003cem\u003eortho\u003c/em\u003e (\u003cstrong\u003e1f\u0026prime;\u003c/strong\u003e) substituent or multiple substituents (\u003cstrong\u003e1g\u0026prime;\u003c/strong\u003e\u0026ndash;\u003cstrong\u003eo\u0026prime;\u003c/strong\u003e) were also amenable to this transformation, giving corresponding hydrogenation products \u003cstrong\u003e2d\u0026prime;\u003c/strong\u003e\u0026ndash;\u003cstrong\u003eo\u0026prime;\u003c/strong\u003e in 94\u0026ndash;99% y with 93\u0026ndash;99% ee. Notably, good tolerance of various functional groups was generally observed as well.\u003c/p\u003e\n\u003cp\u003eHaving developed a protocol for asymmetric hydrogenation reactions to establish the two crucial vicinal stereocenters, we commenced work on the pivotal DOS of cyclolignans, beginning with the divergent synthesis of the well-known cyclolignan PPT and related natural products (Fig. 3). We found that three methods were feasible with comparable results for selective benzylic C\u0026ndash;H oxidation\u003csup\u003e50\u003c/sup\u003e of hydrogenation product \u003cstrong\u003e2p\u003c/strong\u003e: CrO\u003csub\u003e3\u003c/sub\u003e-DMP-, copper-, and photoredox-mediated oxidations, gave desired ketone \u003cstrong\u003e7\u003c/strong\u003e. An aldol reaction of \u003cstrong\u003e7\u003c/strong\u003e with formaldehyde and subsequent lactonization afforded podophyllone (\u003cstrong\u003e8\u003c/strong\u003e), along with some double aldol product \u003cstrong\u003e9\u003c/strong\u003e. Mild Pd-catalyzed reduction of \u003cstrong\u003e8\u003c/strong\u003e with polymethylhydrosiloxane as the reductant\u003csup\u003e51\u003c/sup\u003e was found to be a good alternative to previously reported reducing agents (such as LiBH\u003csub\u003e4\u003c/sub\u003e and L-Selectride) for accessing either (\u0026minus;)-PPT (\u003cstrong\u003e10\u003c/strong\u003e) or deoxypodophyllotoxin (\u003cstrong\u003e11\u003c/strong\u003e). Epimerization of deoxypodophyllotoxin (\u003cstrong\u003e11\u003c/strong\u003e) afforded deoxypicropodophyllotoxin (\u003cstrong\u003e12\u003c/strong\u003e), while sequential reductions of \u003cstrong\u003e11\u003c/strong\u003e completed the first total synthesis of austrobailignan-4 (\u003cstrong\u003e14\u003c/strong\u003e). In addition, a thermal retro-aldol reaction of \u003cstrong\u003e9\u003c/strong\u003e afforded isopicropodophyllone (\u003cstrong\u003e15\u003c/strong\u003e), which could be reduced to generate either epiisopicropodophyllotoxin (\u003cstrong\u003e16\u003c/strong\u003e)\u003csup\u003e52\u003c/sup\u003e or epiisopicrodeoxypodophyllotoxin (\u003cstrong\u003e17\u003c/strong\u003e). Using this new protocol from either \u003cstrong\u003e2k\u0026prime; \u003c/strong\u003eor \u003cstrong\u003e2l\u0026prime;\u003c/strong\u003e, we also synthesized \u0026beta;-peltatin-A-methyether (\u003cstrong\u003e18\u003c/strong\u003e) and accomplished the first total syntheses of epiisopicropodophyllotoxin (\u003cstrong\u003e16\u003c/strong\u003e), 6-methoxypodophyllotoxin (\u003cstrong\u003e19\u003c/strong\u003e), 6-methoxypodophyllotoxin-7-\u003cem\u003eO\u003c/em\u003e-\u003cem\u003en\u003c/em\u003e-hexanoate (\u003cstrong\u003e20\u003c/strong\u003e),\u003csup\u003e53\u003c/sup\u003e cleistantoxin (\u003cstrong\u003e21\u003c/strong\u003e),\u003csup\u003e54\u003c/sup\u003e and picrobursenin (\u003cstrong\u003e22\u003c/strong\u003e)\u003csup\u003e55\u003c/sup\u003e (Fig. 3b).\u003c/p\u003e\n\u003cp\u003eBecause of the electron-withdrawing ester group, \u003cstrong\u003e2p\u003c/strong\u003e could be easily epimerized to provide \u003cstrong\u003e23\u003c/strong\u003e, from which other types of cyclolignans could be readily accessed (Fig. 4). For example, podophyllic aldehyde A (\u003cstrong\u003e25\u003c/strong\u003e) was obtained from \u003cstrong\u003e23 \u003c/strong\u003evia four simple transformations. Global reduction of \u003cstrong\u003e25\u003c/strong\u003e, followed by selective oxidation of the resulting allylic alcohol, provided podophyllic aldehyde C (\u003cstrong\u003e26\u003c/strong\u003e), from which \u0026alpha;-conidendrin analogue \u003cstrong\u003e27\u003c/strong\u003e, oleralignan A analogue \u003cstrong\u003e28\u003c/strong\u003e, and the nominal formosolactone (\u003cstrong\u003e29\u003c/strong\u003e)\u003csup\u003e56\u003c/sup\u003e were prepared via several simple transformations. Meanwhile, converting the ester group of \u003cstrong\u003e23\u003c/strong\u003e to a methyl group paved the way for the synthesis of analogues (\u003cstrong\u003e33-36\u003c/strong\u003e) of 8\u0026rsquo;-\u003cem\u003eepi\u003c/em\u003e-aristoligone, cyclogalgravin analogue, galbulin/galcatin, and 8,8\u0026rsquo;-\u003cem\u003eepi\u003c/em\u003e-aristoligone. We expect that the authentic natural products would be accessible from hydrogenation products \u003cstrong\u003e2l\u003c/strong\u003e or \u003cstrong\u003e2n\u003c/strong\u003e\u003cstrong\u003e\u0026prime;\u003c/strong\u003e\u0026ndash;\u003cstrong\u003ep\u003c/strong\u003e\u003cstrong\u003e\u0026prime; \u003c/strong\u003eby means of the same established sequences.\u003c/p\u003e\n\u003cp\u003eMore types of interesting cyclolignans could be readily synthesized as exemplified from hydrogenation product \u003cstrong\u003e2j\u0026prime;\u003c/strong\u003e in Figs. 5 and 6. For instance, a one-pot selective C\u0026ndash;H oxidation/bromination of \u003cem\u003eent\u003c/em\u003e-\u003cstrong\u003e2j\u0026prime;\u003c/strong\u003e produced brominated ketone intermediate \u003cstrong\u003e44\u003c/strong\u003e, from which \u003cstrong\u003e46\u003c/strong\u003e could be obtained through a one-pot Suzuki/epimerization procedure. Then, a third one-pot transformation, an oxidative cleavage/aldol cyclization, was developed to generate \u003cstrong\u003e47\u003c/strong\u003e, which incorporates the key [3.3.1] structural framework of lirionol. The first asymmetric synthesis of (+)-lirionol (\u003cstrong\u003e50\u003c/strong\u003e) was then accomplished by several additional simple conversions (Fig. 5).\u003csup\u003e57\u003c/sup\u003e Meanwhile, direct selective benzylic oxidation of \u003cem\u003eent\u003c/em\u003e-\u003cstrong\u003e2j\u0026rsquo; \u003c/strong\u003ewith Cu catalysis could afford ketone \u003cstrong\u003e51\u003c/strong\u003e. From this ketone, a compound with the structure reported for aglacin G (\u003cstrong\u003e52\u003c/strong\u003e) was synthesized by means of the protocol illustrated in Fig. 4 for the synthesis of podophyllic aldehyde C (\u003cstrong\u003e26\u003c/strong\u003e), and a compound with the structure reported for aglacin H (\u003cstrong\u003e53\u003c/strong\u003e) was synthesized by a two-step sequence (reduction of the carbonyl groups and selective oxidation of the benzylic alcohol). An aldol reaction of \u003cstrong\u003e53 \u003c/strong\u003ewith formaldehyde and subsequent tetrahydrofuran ring formation by a Mitsunobu-type cyclization completed the synthesis of a compound with the structure reported for aglacin D (\u003cstrong\u003e55\u003c/strong\u003e), acid-mediated epimerization of which provided \u003cstrong\u003e56\u003c/strong\u003e. However, the spectroscopic data for all these synthetic aglacins do not agree with the previously reported data.\u003csup\u003e58,59\u003c/sup\u003e\u003c/p\u003e\n\u003cp\u003eBecause our results suggested that the reported \u003cem\u003esyn\u003c/em\u003e structures of aglacins D, G, and H were incorrect, we speculated the correct structures had \u003cem\u003eanti\u003c/em\u003e configurations and were epimeric at C-7\u0026prime; (i.e., the same configuration as most other cyclolignans). To confirm this assumption, we carried out some structure revision studies using \u003cstrong\u003e2j\u0026prime; \u003c/strong\u003e(Fig. 6). A two-step sequence (one-pot oxidation/bromination followed by epimerization) was used to produce intermediate \u003cstrong\u003e57\u003c/strong\u003e (direct epimerization of \u003cstrong\u003e2j\u0026prime; \u003c/strong\u003eshowed an unsatisfied diastereoselectivity). Reduction of the carbonyl groups with concurrent debromination by LAH were followed by selective oxidation of the benzylic alcohol to afford \u003cstrong\u003e58\u003c/strong\u003e, the spectroscopic data of which matched the data originally reported for aglacin H. Direct treatment of its MEM acetal derivative with TiCl\u003csub\u003e4\u003c/sub\u003e-DBU in DCM at \u0026minus;20 \u0026deg;C could give the cyclization product \u003cstrong\u003e59\u003c/strong\u003e, whose spectroscopic data matched the data originally reported for aglacin D. \u003c/p\u003e\n\u003cp\u003eEncouraged by these results, we set out to obtain the correct structures of aglacin G as well. Unfortunately, a direct aldol reaction of genuine aglacin H (\u003cstrong\u003e58\u003c/strong\u003e) under our previously established conditions (Fig. 4, \u003cstrong\u003e53 \u003c/strong\u003e\u0026rarr; \u003cstrong\u003e54\u003c/strong\u003e) failed, perhaps because of higher steric hindrance in \u003cstrong\u003e57\u003c/strong\u003e than in previous substrates. Gratifyingly, however, an indirect Mukaiyama aldol reaction by means of Kobayashi\u0026rsquo;s protocol was successful, and desired hydroxy ketone was obtained in good yield with a diastereoselectivity of 4.8:1. Hydroxy-directed reduction utilizing Evans\u0026rsquo; protocol gave desired key diol intermediate \u003cstrong\u003e60\u003c/strong\u003e. From \u003cstrong\u003e60\u003c/strong\u003e, we could obtain \u003cstrong\u003e61\u003c/strong\u003e in good yield via a two-step sequence involving selective oxidative dehydration that afforded the \u0026alpha;,\u0026beta;-unsaturated aldehyde and free of the primary alcohol; the spectroscopic data of this compound matched the data originally reported for aglacin G.\u003c/p\u003e\n\u003cp\u003eIn addition, lyoniresinol dimethyl ether (\u003cstrong\u003e62\u003c/strong\u003e) was obtained by selective benzylic deoxygenation with concurrent removal of the silyl group from \u003cstrong\u003e60\u003c/strong\u003e. Subsequent selective demethylation mediated by MgI\u003csub\u003e2 \u003c/sub\u003eprovided lyoniresinol (\u003cstrong\u003e63\u003c/strong\u003e), while formation of a tetrahydrofuran ring generated aglacin B (\u003cstrong\u003e64\u003c/strong\u003e). The direct oxidation of aglacin B to give aglacins E or F was then investigated, but various benzylic oxidation methods proved unsuccessful in this case.\u003csup\u003e50 \u003c/sup\u003eTo our delight, the very recent advance by Parasram and co-workers,\u003csup\u003e60\u003c/sup\u003e via exploring the interesting synergistic nature of photoexcited nitroarenes, was found to be possible for this challenging case, and aglacins E (\u003cstrong\u003e65\u003c/strong\u003e) or F (\u003cstrong\u003e66\u003c/strong\u003e) were accessed albeit with poor conversions and low yields. From (+)-aglacin F (\u003cstrong\u003e66\u003c/strong\u003e), (+)-aglacin A (\u003cstrong\u003e67\u003c/strong\u003e) was obtained by simple acetylation. On the other hand, selective tosylation of the primary alcohol of intermediate \u003cstrong\u003e60\u003c/strong\u003e, and subsequent tetrahydrofuran ring formation triggered by removal of the \u003cem\u003etert\u003c/em\u003e-butyldimethylsilyl group in one pot delivered (+)-aglacin E (\u003cstrong\u003e65\u003c/strong\u003e) in good yield. Its oxidation by PDC afforded ketone \u003cstrong\u003e68\u003c/strong\u003e. Its reduction by CBS could also provide aglacins E (\u003cstrong\u003e65\u003c/strong\u003e) and F (\u003cstrong\u003e66\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003eThe first total synthesis of the distinctive cyclolignan ovafolinin D (\u003cstrong\u003e72\u003c/strong\u003e)\u003csup\u003e61\u003c/sup\u003e was also accomplished from hydrogenation product \u003cstrong\u003e2k\u0026prime;\u003c/strong\u003e. Following the established synthetic sequence for \u003cstrong\u003e54\u003c/strong\u003e (Fig. 5), its enantiomer \u003cem\u003eent\u003c/em\u003e-\u003cstrong\u003e54\u003c/strong\u003e could be easily accessed from \u003cstrong\u003e2k\u0026prime;\u003c/strong\u003e. After that, hydroxy-directed reduction of \u003cem\u003eent\u003c/em\u003e-\u003cstrong\u003e54\u003c/strong\u003e followed by Lewis acid\u0026ndash;promoted cyclization produced \u003cstrong\u003e69\u003c/strong\u003e, which has one of the tetrahydrofuran rings of ovafolinin D; the absolute configuration of \u003cstrong\u003e69 \u003c/strong\u003ewas unambiguously confirmed by X-ray analysis of its ester derivative \u003cstrong\u003e70\u003c/strong\u003e. The other tetrahydrofuran ring of ovafolinin D was then constructed via radical-initiated oxidative cyclization, and a final selective demethylation achieved by means of MgI\u003csub\u003e2\u003c/sub\u003e completed its first total synthesis.\u003c/p\u003e\n\u003cp\u003eJust as importantly, the current asymmetric hydrogenation protocol is also applicable to tetrasubstituted 1,2-dihydronaphthalene esters readily derivable from 2-tetralones. For instance, subjection of olefin \u003cstrong\u003e73\u003c/strong\u003e to the standard conditions with (\u003cem\u003eR\u003c/em\u003e,\u003cem\u003eR\u003c/em\u003e)-PTBP as the ligand provided the desired hydrogenation product \u003cstrong\u003e74\u003c/strong\u003e in good results (93% y, 84% ee); this paved the way for the first synthesis of fimbricalyxoid A (\u003cstrong\u003e82\u003c/strong\u003e, Fig. 7).\u003csup\u003e62\u003c/sup\u003e Treatment of\u003cstrong\u003e 74\u003c/strong\u003e with \u003cem\u003ep\u003c/em\u003e-TSA in a mixture of acetone and water released the aldehyde functionality, which was trapped by phosphorus ylide to give alkene \u003cstrong\u003e75\u003c/strong\u003e. Epimerization was observed under the Wittig reaction conditions, but this has no influence on the following vinylation. Its vinylation with ethyl\u003cem\u003e \u003c/em\u003eZ-3-bromoacrylate delivered diene \u003cstrong\u003e76\u003c/strong\u003e in good yield. Subsequent ring-closing metathesis (RCM) promoted by a second-generation Grubbs\u0026apos; catalyst completed the construction of the carbon cyclic framework of fimbricalyxoid A to afford \u003cstrong\u003e77\u003c/strong\u003e. Ensuing ketone formation by a one-pot selective allylic oxidation and followed by the introduction of the two methyl groups furnished key intermediate \u003cstrong\u003e78\u003c/strong\u003e. Pleasantly, mono-demethylation of \u003cstrong\u003e78\u003c/strong\u003e was feasible, and the desired phenol \u003cstrong\u003e79\u003c/strong\u003e was obtained as the major product, while the undesired regioisomer and diphenol could be converted back to \u003cstrong\u003e78 \u003c/strong\u003ethough simple methylation. The vinyl group at C-14 was then introduced via Suzuki-Miyaura coupling. Afterwards, conjugate reduction of \u003cstrong\u003e80\u003c/strong\u003e by modifying a Pd-catalyzed hydrosilylation and ketone protection provided intermediate \u003cstrong\u003e81\u003c/strong\u003e.\u003csup\u003e63,64\u003c/sup\u003e Finally, ester reduction followed by concurrent demethylation and oxybridge formation via ketone releasement and hemiketal formation,\u003csup\u003e65\u003c/sup\u003e completed the first total synthesis of (+)-fimbricalyxoid A (\u003cstrong\u003e82\u003c/strong\u003e).\u003c/p\u003e\n\u003cp\u003eTo conclude, we have developed a powerful new platform for cyclolignan synthesis with ideal modularity and diversity. The syntheses were facilitated by unprecedented Rh-Skewphos-catalyzed enantioselective hydrogenation reactions of dihydronaphthalene tetrasubstituted \u0026alpha;,\u0026beta;-unsaturated carboxylic acid esters, which exhibited excellent outcomes (\u0026gt;40 examples; up to 99% y, \u0026gt;99% ee). The generality of this DOS was demonstrated by our syntheses of over 30 cyclolignans, including the first total syntheses of 6-methoxypodophyllotoxin, 6-methoxypodophyllotoxin-7-\u003cem\u003eO\u003c/em\u003e-n-hexanoate, cleistantoxin, picrobursenin, austrobailignan-4, aglacins D and F\u0026ndash;H, (+)-lirionol, ovafolinin D and fimbricalyxoid A. Subsequent work on de novo DOS of other types of natural products via state-of-the-art asymmetric catalysis, as well as drug development based on the findings of this study, is underway in our laboratory. \u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eAcknowledgements:\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWe are grateful to the National Natural Science Foundation of China (no. 22271236) and the Natural Science Foundation of Zhejiang Province (no. LXZ22B020001) for support of this research. We sincerely thank Professor Thomas J. Schmidt (University of M\u0026uuml;nster) as well as Professor Young Sook Yun (Tokyo University of Pharmacy and Life Sciences) for kindly providing us their original NMR spectra of 6-methoxypodophyllotoxin-7-\u003cem\u003eO\u003c/em\u003e-n-hexanoate and ovafonin D respectively. We acknowledge the Instrumentation and Service Centre for Molecular Sciences at Westlake University for help with measurement and data interpretation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthor contributions:\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eH.H.L. conceived the project, guided the studies, and wrote the manuscript. Z.P. developed the asymmetric hydrogenation and completed the synthesis of podophyllotoxins and related cyclolignans. W.X.X completed the syntheses of (+)-lirionol, aglacins, ovafolinin D and fimbricalyxoid A. Q.X.G., Y.Z. and L.H.Z. helped with the preparation of some intermediates. All the authors contributed to the analysis and interpretation of the results.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSupplementary Information:\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026bull; Experimental procedures and characterization data for all new compounds\u003c/p\u003e\n\u003cp\u003e\u0026bull; NMR and HPLC spectra for all for all new compounds\u003c/p\u003e\n\u003cp\u003e\u0026bull; X-ray data for compounds \u003cstrong\u003e2p\u003c/strong\u003e, \u003cstrong\u003e9\u003c/strong\u003e, \u003cstrong\u003e16\u003c/strong\u003e, \u003cstrong\u003e47\u003c/strong\u003e, and \u003cstrong\u003e70\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests:\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare no competing financial interests.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eShen, B. A new golden age of natural products drug discovery. \u003cem\u003eCell\u003c/em\u003e \u003cstrong\u003e163\u003c/strong\u003e, 1297\u0026ndash;1300 (2015).\u003c/li\u003e\n\u003cli\u003eRodrigues, T. et al. Counting on natural products for drug design. \u003cem\u003eNat. Chem.\u003c/em\u003e \u003cstrong\u003e8\u003c/strong\u003e, 531\u0026ndash;541 (2016).\u003c/li\u003e\n\u003cli\u003eNewman, D. J. \u0026amp; Cragg, G. M. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. \u003cem\u003eJ. Nat. Prod.\u003c/em\u003e \u003cstrong\u003e83\u003c/strong\u003e, 770-803 (2020).\u003c/li\u003e\n\u003cli\u003eWright, P. M., Seiple, I. B. \u0026amp; Myers, A. G. The evolving role of chemical synthesis in antibacterial drug discovery. \u003cem\u003eAngew. Chem. Int. Ed.\u003c/em\u003e \u003cstrong\u003e53\u003c/strong\u003e, 8840\u0026ndash;8869 (2014).\u003c/li\u003e\n\u003cli\u003eAllred, T. K.; Manoni, F. \u0026amp; Patrick G. Harran, Exploring the boundaries of \u0026ldquo;practical\u0026rdquo;: de novo syntheses of complex natural product-based drug candidates. \u003cem\u003eChem. Rev. \u003c/em\u003e\u003cstrong\u003e117\u003c/strong\u003e, 11994\u0026ndash;1205 (2017).\u003c/li\u003e\n\u003cli\u003eSchreiber, S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. \u003cem\u003eScience\u003c/em\u003e \u003cstrong\u003e287\u003c/strong\u003e, 1964\u0026ndash;1969 (2000).\u003c/li\u003e\n\u003cli\u003eLi, L.; Chen, Z.; Zhang, X. \u0026amp; Jia, Y. Divergent strategy in natural product total synthesis. \u003cem\u003eChem. Rev.\u003c/em\u003e \u003cstrong\u003e118\u003c/strong\u003e, 3752\u0026ndash;3832 (2018). \u003c/li\u003e\n\u003cli\u003eCharest, M. G.; Lerner, C. D.; Brubaker, J. D.; Siegel, D. R. \u0026amp; Myers, A. G. A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics. \u003cem\u003eScience\u003c/em\u003e \u003cstrong\u003e308\u003c/strong\u003e, 395\u0026ndash;398 (2005).\u003c/li\u003e\n\u003cli\u003eSeiple, I. B. et al. A platform for the discovery of new macrolide antibiotics. \u003cem\u003eNature\u003c/em\u003e \u003cstrong\u003e533\u003c/strong\u003e, 338\u0026ndash;345 (2016).\u003c/li\u003e\n\u003cli\u003eLi, Q. et al. Synthetic group A streptogramin antibiotics that overcome Vat resistance. \u003cem\u003eNature\u003c/em\u003e \u003cstrong\u003e586\u003c/strong\u003e, 145\u0026ndash;150 (2020).\u003c/li\u003e\n\u003cli\u003eMitcheltree, M. J. et al. A synthetic antibiotic class overcoming bacterial multidrug resistance. \u003cem\u003eNature\u003c/em\u003e \u003cstrong\u003e599\u003c/strong\u003e, 507\u0026ndash;512 (2021).\u003c/li\u003e\n\u003cli\u003eSmith, P. A. et al. Optimized arylomycins are a new class of Gram-negative antibiotics. \u003cem\u003eNature\u003c/em\u003e \u003cstrong\u003e651\u003c/strong\u003e, 189\u0026ndash;194 (2018).\u003c/li\u003e\n\u003cli\u003eMurphy, S. K.; Zeng, M. \u0026amp; Herzon, S. B. A modular and enantioselective synthesis of the pleuromutilin antibiotics. \u003cem\u003eScience\u003c/em\u003e \u003cstrong\u003e356\u003c/strong\u003e, 956\u0026ndash;959 (2017).\u003c/li\u003e\n\u003cli\u003eWang, X. et al. A radical cascade enabling collective syntheses of natural products. \u003cem\u003eChem\u003c/em\u003e \u003cstrong\u003e2\u003c/strong\u003e, 803\u0026ndash;816 (2017).\u003c/li\u003e\n\u003cli\u003eZhang, X. et al. Divergent synthesis of complex diterpenes through a hybrid oxidative approach.\u003cem\u003e Science\u003c/em\u003e \u003cstrong\u003e369\u003c/strong\u003e, 799\u0026ndash;806 (2020).\u003c/li\u003e\n\u003cli\u003eHarwood, S. J. et al. Modular terpene synthesis enabled by mild electrochemical couplings.\u003cem\u003e Science\u003c/em\u003e \u003cstrong\u003e375\u003c/strong\u003e, 745\u0026ndash;752 (2022).\u003c/li\u003e\n\u003cli\u003eScharf, M. J. \u0026amp; List, B. A catalytic asymmetric Pictet-Spengler platform as a biomimetic diversification strategy toward naturally occurring alkaloids. \u003cem\u003eJ. Am. Chem. Soc. \u003c/em\u003e\u003cstrong\u003e144\u003c/strong\u003e,\u003cem\u003e \u003c/em\u003e15451\u0026ndash;15456 (2022).\u003c/li\u003e\n\u003cli\u003eGoethe, O.; DiBello, M. \u0026amp; Herzon, S. B. Total synthesis of structurally diverse pleuromutilin antibiotics. \u003cem\u003eNat. Chem.\u003c/em\u003e \u003cstrong\u003e14\u003c/strong\u003e, 1270\u0026ndash;1277 (2022).\u003c/li\u003e\n\u003cli\u003eBruno, B.; Giulliano Delle, M.; Domenico, M.; Alberto, V. \u0026amp; Giovanni, Z. Aryltetralin lignans: chemistry, pharmacology and biotransformations. \u003cem\u003eCurr. Med. Chem.\u003c/em\u003e \u003cstrong\u003e8\u003c/strong\u003e, 1363-1381 (2001).\u003c/li\u003e\n\u003cli\u003eVass\u0026atilde;o, D. G.; Kim, K.-W.; Davin, L. B. \u0026amp; Lewis, N. G. Lignans (neolignans) and allyl/propenyl phenols: biogenesis, structural biology, and biological/human health considerations. In\u003cem\u003e Comprehensive Natural Products II\u003c/em\u003e; H.-W. Liu \u0026amp; L. Mander Eds.; Elsevier, pp. 815\u0026ndash;928 (2010).\u003c/li\u003e\n\u003cli\u003eShah, Z. et al. Podophyllotoxin: History, recent advances and future prospects, \u003cem\u003eBiomolecules\u003c/em\u003e \u003cstrong\u003e11\u003c/strong\u003e, 603\u0026ndash;630 (2021).\u003c/li\u003e\n\u003cli\u003eYu, X.; Che, Z. \u0026amp; Xu, H. Recent advances in the chemistry and biology of podophyllotoxins. \u003cem\u003eChem. Eur. J.\u003c/em\u003e \u003cstrong\u003e23\u003c/strong\u003e, 4467\u0026ndash;4526 (2017).\u003c/li\u003e\n\u003cli\u003eZhao, W. et al. Challenges and Potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy. \u003cem\u003eNat. Prod. Rep.\u003c/em\u003e \u003cstrong\u003e38\u003c/strong\u003e, 470\u0026ndash;488 (2021).\u003c/li\u003e\n\u003cli\u003eReynolds, R. G.; Nguyen, H. Q. A.; Reddel, J. C. T. \u0026amp; Thomson, R. J. Recent strategies and tactics for the enantioselective total syntheses of cyclolignan natural products. \u003cem\u003eNat. Prod. Rep.\u003c/em\u003e \u003cstrong\u003e39\u003c/strong\u003e, 670\u0026ndash;702 (2022).\u003c/li\u003e\n\u003cli\u003eFang, X. \u0026amp; Hu, X. Advances in the synthesis of lignan natural products. \u003cem\u003eMolecules\u003c/em\u003e \u003cstrong\u003e23\u003c/strong\u003e, 3385 (2018).\u003c/li\u003e\n\u003cli\u003eReddel, J. C. T.; Lutz, K. E.; Diagne, A. B. \u0026amp; Thomson, R. J. Stereocontrolled syntheses of tetralone and naphthyl-type lignans by a one-pot oxidative [3,3] rearrangement/Friedel\u0026ndash;Crafts arylation, \u003cem\u003eAngew. Chem. Int. Ed.\u003c/em\u003e \u003cstrong\u003e53\u003c/strong\u003e, 1395\u0026ndash;1398 (2014). \u003c/li\u003e\n\u003cli\u003eTing, C. P. \u0026amp; Maimone, T. J. C-H Bond arylation in the synthesis of aryltetralin lignans: A short total synthesis of podophyllotoxin. \u003cem\u003eAngew. Chem. Int. Ed.\u003c/em\u003e \u003cstrong\u003e53\u003c/strong\u003e, 3115\u0026ndash;3119 (2014).\u003c/li\u003e\n\u003cli\u003eHajra, S.; Garai, S. \u0026amp; Hazra, S. Catalytic enantioselective synthesis of (-)-podophyllotoxin. \u003cem\u003eOrg. Lett.\u003c/em\u003e \u003cstrong\u003e19\u003c/strong\u003e, 6530\u0026ndash;6533 (2017).\u003c/li\u003e\n\u003cli\u003eXiao, J.; Cong, X.-W.; Yang, G.-Z.; Wang, Y.-W. \u0026amp; Peng, Y. Divergent asymmetric syntheses of podophyllotoxin and related family members via stereoselective reductive Ni-catalysis. \u003cem\u003eOrg. Lett.\u003c/em\u003e \u003cstrong\u003e20\u003c/strong\u003e, 1651\u0026ndash;1654 (2018).\u003c/li\u003e\n\u003cli\u003eLi, J.; Zhang, X. \u0026amp; Renata, H. Asymmetric Chemoenzymatic Synthesis of (-)-Podophyllotoxin and Related Aryltetralin Lignans. \u003cem\u003eAngew. Chem. Int. Ed.\u003c/em\u003e \u003cstrong\u003e58\u003c/strong\u003e, 11657\u0026ndash;11660 (2019).\u003c/li\u003e\n\u003cli\u003eLazzarotto, M. et al. Chemoenzymatic total synthesis of deoxy-, \u003cem\u003eepi\u003c/em\u003e-, and podophyllotoxin and a biocatalytic kinetic resolution of dibenzylbutyrolactones. \u003cem\u003eAngew. Chem. Int. Ed.\u003c/em\u003e \u003cstrong\u003e58\u003c/strong\u003e, 8226\u0026ndash;8230 (2019).\u003c/li\u003e\n\u003cli\u003eXiang, J-C.; Wang, Q. \u0026amp; Zhu, J. Radical-cation cascade to aryltetralin cyclic ether lignans under visible-light photoredox catalysis. \u003cem\u003eAngew. Chem. Int. Ed. \u003c/em\u003e\u003cstrong\u003e59\u003c/strong\u003e, 21195\u0026ndash;21202 (2020).\u003c/li\u003e\n\u003cli\u003eXu, M.; Hou, M.; He, H. \u0026amp; Gao, S. Asymmetric total synthesis of aglacins A, B, and E. \u003cem\u003eAngew. Chem. Int. Ed.\u003c/em\u003e \u003cstrong\u003e60\u003c/strong\u003e, 16655\u0026ndash;16660 (2021).\u003c/li\u003e\n\u003cli\u003eCao, M.-Y. et al. Optically active flavaglines-inspired molecules by a palladium-catalyzed decarboxylative dearomative asymmetric allylic alkylation. \u003cem\u003eJ. Am. Chem. Soc.\u003c/em\u003e \u003cstrong\u003e142\u003c/strong\u003e, 12039\u0026ndash;12045 (2020).\u003c/li\u003e\n\u003cli\u003eCao, M.-Y.; Ma, B.-J.; Gu, Q.-X.; Fu, B. \u0026amp; Lu, H.-H. Concise enantioselective total synthesis of daphenylline enabled by an intramolecular oxidative dearomatization. \u003cem\u003eJ. Am. Chem. Soc.\u003c/em\u003e \u003cstrong\u003e144\u003c/strong\u003e, 5750\u0026ndash;5755 (2022).\u003c/li\u003e\n\u003cli\u003eFor a lead perspective, see: Kraft, S.; Ryan, K. \u0026amp; Kargbo, R. B. Recent advances in asymmetric hydrogenation of tetrasubstituted olefins. \u003cem\u003eJ. Am. Chem. Soc.\u003c/em\u003e \u003cstrong\u003e139\u003c/strong\u003e, 11630\u0026ndash;11641 (2017).\u003c/li\u003e\n\u003cli\u003eSong, S.; Zhu, S.-F.; Li, Y. \u0026amp; Zhou, Q.-L. Iridium-catalyzed enantioselective hydrogenation of \u0026alpha;,\u0026beta;-unsaturated carboxylic acids with tetrasubstituted olefins, \u003cem\u003eOrg. Lett.\u003c/em\u003e \u003cstrong\u003e15\u003c/strong\u003e, 3722\u0026ndash;3725 (2013). \u003c/li\u003e\n\u003cli\u003eDu, X. et al. Enantioselective hydrogenation of tetrasubstituted \u0026alpha;,\u0026beta;-unsaturated carboxylic acids enabled by cobalt(II) catalysis: scope and mechanistic insights, \u003cem\u003eAngew. Chem. Int. Ed.\u003c/em\u003e \u003cstrong\u003e60\u003c/strong\u003e, 11384\u0026ndash;11390 (2021).\u003c/li\u003e\n\u003cli\u003eChen, G.-Q. et al. Highly Enantioselective hydrogenation of \u003cem\u003etetra\u003c/em\u003e- and \u003cem\u003etri\u003c/em\u003e-substituted \u0026alpha;,\u0026beta;-unsaturated carboxylic acids with \u003cem\u003eoxa\u003c/em\u003e-spiro diphosphine ligands. \u003cem\u003eCCS chem.\u003c/em\u003e \u003cstrong\u003e2\u003c/strong\u003e, 468\u0026ndash;477 (2020).\u003c/li\u003e\n\u003cli\u003eMolinaro, C. et al. A practical synthesis of renin inhibitor MK-1597 (ACT-178882) via catalytic enantioselective hydrogenation and epimerization of piperidine intermediate.\u003cem\u003e J. Org. Chem.\u003c/em\u003e \u003cstrong\u003e76\u003c/strong\u003e, 1062\u0026ndash;1071 (2011).\u003c/li\u003e\n\u003cli\u003eChristensen, M. et al. Enantioselective synthesis of \u0026alpha;-methyl-\u0026beta;-cyclopropyldihydrocinnamates. \u003cem\u003eJ. Org. Chem.\u003c/em\u003e \u003cstrong\u003e81\u003c/strong\u003e, 824\u0026ndash;830 (2016).\u003c/li\u003e\n\u003cli\u003eKerdphon, S. et al. Diastereo- and enantioselective synthesis of structurally diverse succinate, butyrolactone, and trifluoromethyl derivatives by Iridium-catalyzed hydrogenation of tetrasubstituted olefins. \u003cem\u003eACS Catal.\u003c/em\u003e \u003cstrong\u003e9\u003c/strong\u003e, 6169\u0026minus;6176 (2019).\u003c/li\u003e\n\u003cli\u003eTroutman, M. V.; Appella, D. H. \u0026amp; Buchwald, S. L. Asymmetric hydrogenation of unfunctionalized tetrasubstituted olefins with a cationic zirconocene catalyst, \u003cem\u003eJ. Am. Chem. Soc.\u003c/em\u003e \u003cstrong\u003e121\u003c/strong\u003e, 4916\u0026ndash;4917 (1999). \u003c/li\u003e\n\u003cli\u003eSchrems, M. G.; Neumann, E. \u0026amp; Pfaltz, A. Iridium-catalyzed asymmetric hydrogenation of unfunctionalized tetrasubstituted olefins. \u003cem\u003eAngew. Chem. Int. Ed.\u003c/em\u003e \u003cstrong\u003e46\u003c/strong\u003e, 8274\u0026ndash;8276 (2007).\u003c/li\u003e\n\u003cli\u003eZanotti-Gerosa, A.; Gazić Smilović, I. \u0026amp; Časar, Z. Acid promoted Ir\u0026ndash;P^N complex catalyzed hydrogenation of heavily hindered 3,4-diphenyl-1,2-dihydronaphthalenes: asymmetric synthesis of lasofoxifene tartrate, \u003cem\u003eOrg. Chem. Front.\u003c/em\u003e \u003cstrong\u003e4\u003c/strong\u003e, 2311\u0026ndash;2322 (2017).\u003c/li\u003e\n\u003cli\u003eBiosca, M. et al. Extending the substrate scope in the hydrogenation of unfunctionalized tetrasubstituted olefins with Ir-P stereogenic aminophosphine-oxazoline Catalysts. \u003cem\u003eOrg. Lett. \u003c/em\u003e\u003cstrong\u003e21\u003c/strong\u003e, 807\u0026ndash;811 (2019).\u003c/li\u003e\n\u003cli\u003eZhang, Z.; Zhu, G.; Jiang, Q.; Xiao, D. \u0026amp; Zhang, X. Highly Enantioselective Hydrogenation of Cyclic Enamides Catalyzed by a Rh-PennPhos Catalyst. \u003cem\u003eJ. Org. Chem.\u003c/em\u003e \u003cstrong\u003e64\u003c/strong\u003e, 1774\u0026ndash;1775 (1999).\u003c/li\u003e\n\u003cli\u003eYue, T.-Y. \u0026amp; Nugent, W. A. Enantioselective hydrogenation of 3-alkylidenelactams:\u0026thinsp; high-throughput screening provides a surprising solution. \u003cem\u003eJ. Am. Chem. Soc.\u003c/em\u003e \u003cstrong\u003e124\u003c/strong\u003e, 13692\u0026ndash;13693 (2002).\u003c/li\u003e\n\u003cli\u003eLu, S. \u0026amp; Alper, H. Sequence of intramolecular carbonylation and asymmetric hydrogenation reactions: highly regio- and enantioselective synthesis of medium ring tricyclic lactams.\u003cem\u003e J. Am. Chem. Soc.\u003c/em\u003e \u003cstrong\u003e130\u003c/strong\u003e, 6451\u0026ndash;6455 (2008). \u003c/li\u003e\n\u003cli\u003eLubov, D. P.; Talsi, E. P. \u0026amp; Bryliakov, K. P. Methods for selective benzylic C\u0026ndash;H oxofunctionalization of organic compounds.\u003cem\u003e Russ. Chem. Rev.\u003c/em\u003e \u003cstrong\u003e89\u003c/strong\u003e, 587\u0026ndash;628 (2020).\u003c/li\u003e\n\u003cli\u003eLawrence, N. J.; Drew, M. D. \u0026amp; Bushell, S. M. Polymethylhydrosiloxane: a versatile reducing agent for organic synthesis. \u003cem\u003eJ. Chem. Soc., Perkin Trans. 1\u003c/em\u003e, 3381\u0026ndash;3391 (1999).\u003c/li\u003e\n\u003cli\u003ePrevious efforts to synthesize this cyclolignan were reported to be unsuccessful, see: Forsey, S. P.; Rajapaksa, D.; Taylor, N. J. \u0026amp; Rodrigo, R. Comprehensive synthetic route to eight diastereomeric podophyllum lignans.\u003cem\u003e J. Org. Chem. \u003c/em\u003e\u003cstrong\u003e54\u003c/strong\u003e, 4280\u0026ndash;4290 (1989). \u003c/li\u003e\n\u003cli\u003eKlaes, M.; Ellendorff, T; Schmidt, T.-S. 6-Methoxypodophyllotoxin-7-\u003cem\u003eO\u003c/em\u003e-n-hexanoate, a new aryltetralin lignan ester from seeds of \u003cem\u003eLinum flavum\u003c/em\u003e. \u003cem\u003ePlanta Med. \u003c/em\u003e\u003cstrong\u003e76\u003c/strong\u003e, 719\u0026ndash;721 (2010).\u003c/li\u003e\n\u003cli\u003eThanh, V. T. T.; Pham, V.-C.; Mai, H.-D. T.; Litaudon, M.; Gueritte, F.; Retailleau, P.; Nguyen, V. H.; Chau, V. M. J. Cytotoxic lignans from fruits of \u003cem\u003eCleistanthus indochinensis\u003c/em\u003e: synthesis of cleistantoxin derivatives.\u003cem\u003e J. Nat. Prod. \u003c/em\u003e\u003cstrong\u003e75\u003c/strong\u003e, 1578\u0026ndash;1583 (2012).\u003c/li\u003e\n\u003cli\u003eThanh, V. T. T.; Pham, V.-M.; Mai, H. D. T.; Litaudon, M.; Gu\u0026eacute;ritte, F.; Nguyen, V.-H.; Chau, V. M. Cytotoxic aryltetralin lignans from fruits of \u003cem\u003eCleistanthus indochinensis\u003c/em\u003e. \u003cem\u003ePlanta Med.\u003c/em\u003e \u003cstrong\u003e80\u003c/strong\u003e, 695\u0026ndash;702 (2014).\u003c/li\u003e\n\u003cli\u003eIts spectroscopic data does not agree with the previously reported data, which we found to agree well with deoxypodophyllotoxin \u003cstrong\u003e11\u003c/strong\u003e, see: Kuo, Y.-H.; Yu, M.-T. A new lignan, formosalactone, from the bark of \u003cem\u003eJuniperus formosana\u003c/em\u003e Hay. \u003cem\u003evar. \u003c/em\u003econcolor Hay. \u003cem\u003eHeterocycles\u003c/em\u003e \u003cstrong\u003e36\u003c/strong\u003e, 529\u0026ndash;535 (1993).\u003c/li\u003e\n\u003cli\u003eWeeratunga, G. Rajapaksa, D. \u0026amp; Rodrigo, R. The synthesis and relative configuration of (\u0026plusmn;)-lirionol.\u003cem\u003e J. Org. Chem.\u003c/em\u003e \u003cstrong\u003e50\u003c/strong\u003e, 5902\u0026ndash;5905 (1985).\u003c/li\u003e\n\u003cli\u003eWang, B.-G. et al. Aglacins A-D, first representatives of a new class of aryltetralin cyclic ether lignans from \u003cem\u003eAglaia cordata\u003c/em\u003e. \u003cem\u003eJ. Nat. Prod. \u003c/em\u003e\u003cstrong\u003e64\u003c/strong\u003e, 1521\u0026ndash;1526 (2001).\u003c/li\u003e\n\u003cli\u003eWang, B.-G.; Ebel, R.; Wang, C.-Y.; Wray, V. \u0026amp; Proksch, P. New methoxylated aryltetrahydronaphthalene lignans and a norlignan from \u003cem\u003eAglaia cordata\u003c/em\u003e. \u003cem\u003eTetrahedron Lett.\u003c/em\u003e \u003cstrong\u003e43\u003c/strong\u003e, 5783\u0026ndash;5787 (2002).\u003c/li\u003e\n\u003cli\u003ePaolillo, J. M.; Duke, A. D.; Gogarnoiu, E. S.; Wise, D. E. \u0026amp; Parasram, M. Anaerobic hydroxylation of C(sp\u003csup\u003e3\u003c/sup\u003e)\u0026ndash;H bonds enabled by the synergistic nature of photoexcited nitroarenes. \u003cem\u003eJ. Am. Chem. Soc.\u003c/em\u003e \u003cstrong\u003e145\u003c/strong\u003e, 2794\u0026ndash;2799 (2023).\u003c/li\u003e\n\u003cli\u003eKashima, K. et al. Ovafolinins A-E, five new lignans from \u003cem\u003eLyonia ovalifolia\u003c/em\u003e. \u003cem\u003eChem. Pharm. Bull.\u003c/em\u003e \u003cstrong\u003e58\u003c/strong\u003e, 191\u0026ndash;194 (2010).\u003c/li\u003e\n\u003cli\u003eChao, C.-H. et al. Terpenoids from \u003cem\u003eFlueggea virosa\u003c/em\u003e and their anti-hepatitis C virus activity. \u003cem\u003ePhytochemistry\u003c/em\u003e \u003cstrong\u003e128\u003c/strong\u003e, 60\u0026ndash;70 (2016).\u003c/li\u003e\n\u003cli\u003eZhang, P. et al. A neural network model informs the total synthesis of clovane sesquiterpenoids. \u003cem\u003eNat. Synth.\u003c/em\u003e DOI: 10.1038/s44160-023-00271-0 (2023).\u003c/li\u003e\n\u003cli\u003eBenohoud, M.; Tuokko, S. \u0026amp; Pihko, P. M. Stereoselective hydrosilylation of enals and enones catalysed by palladium nanoparticles. \u003cem\u003eChem. Eur. J.\u003c/em\u003e \u003cstrong\u003e17\u003c/strong\u003e, 8404\u0026ndash;8413 (2011).\u003c/li\u003e\n\u003cli\u003eLi, L.-P. et al. Total synthesis of the alleged structure of (+)-fimbricalyxoid A. \u003cem\u003eOrg. Lett. \u003c/em\u003e\u003cstrong\u003e24\u003c/strong\u003e, 3477\u0026ndash;3481 (2022).\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-2924400/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-2924400/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"All Birds with One Stone: Natural products have long been valuable sources of inspiration for drug discovery. Unfortunately, the inherent limitations of direct semisynthetic derivatizations have become more and more obvious, and the need to overcome these limitations is particularly urgent nowadays because the most valuable natural products tend to be isolated in minute amounts. Therefore, de novo synthesis with ideal modularity and diversity, have been a critical goal in drug discovery research. However, this endeavor of complex natural products is highly challenging, and only limited success has been achieved so far. Herein, we report a powerful, general platform for cyclolignan synthesis involving challenging rhodium-catalyzed enantioselective hydrogenation of tetrasubstituted 1,2-dihydronaphthalene esters (\u003e 40 examples; up to 99% y, \u003e99% ee). This unique platform allows ready access to various types of cyclolignans, as exemplified by the expedient and mostly protecting-group-free synthesis of over thirty cyclolignans, including many that have not previously been synthesized, such as 6-methoxy podophyllotoxin, cleistantoxin, picrobursenin, austrobailignan-4, aglacins D and F-H (with three revised structures), (+)-lirionol, ovafolinin D, and fimbricalyxoid A. We expect this work to inspire modular, de novo diversity-oriented syntheses of other important classes of natural products and thus to rejuvenate the role of natural products in drug discovery and development.","manuscriptTitle":"Cyclolignan Synthesis Streamlined by Enantioselective Hydrogenation of Tetrasubstituted Olefins","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-01-08 17:35:26","doi":"10.21203/rs.3.rs-2924400/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"nature-synthesis","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"natsynth","sideBox":"Learn more about [Nature Synthesis](https://www.nature.com/natsynth/)","snPcode":"","submissionUrl":"https://mts-natsynth.nature.com/cgi-bin/main.plex","title":"Nature Synthesis","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Research","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"5f834aa4-c4cc-42b4-8b78-d672f15ef6c2","owner":[],"postedDate":"January 8th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":21661514,"name":"Physical sciences/Chemistry/Chemical synthesis/Asymmetric synthesis"},{"id":21661515,"name":"Physical sciences/Chemistry/Chemical synthesis/Diversity-oriented synthesis"}],"tags":[],"updatedAt":"2024-06-21T07:06:11+00:00","versionOfRecord":{"articleIdentity":"rs-2924400","link":"https://doi.org/10.1038/s44160-024-00564-y","journal":{"identity":"nature-synthesis","isVorOnly":false,"title":"Nature Synthesis"},"publishedOn":"2024-06-20 04:00:00","publishedOnDateReadable":"June 20th, 2024"},"versionCreatedAt":"2024-01-08 17:35:26","video":"","vorDoi":"10.1038/s44160-024-00564-y","vorDoiUrl":"https://doi.org/10.1038/s44160-024-00564-y","workflowStages":[]},"version":"v1","identity":"rs-2924400","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-2924400","identity":"rs-2924400","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}